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Cryphonectria parasitica is the causal agent of chestnut blight, which devastated 
the American Chestnut tree population in the early 20th century. The discovery of 
hypoviruses that reduce the severity of the chestnut blight infection offers the potential
for biological control. However, the spread of the hypoviruses is hampered by a diverse
genetically controlled nonself-recognition system, vegetative incompatibility 
(vic). CPVIB-1 was identified as a transcription regulator playing an important role in the
programmed cell death response to this stimulus. In this study, we have found that
CPVIB-1 is ubiquitin-decorated which might lead to its degradation in the proteasome
pathway. RNA-Seq and ChIP-Seq were used to further explore the downstream targets of 
CPVIB-1 that mediate the various metabolic changes that lead to the altered phenotype of
the Δcpvib-1 mutant. Due to inaccuracies in the prior annotation, we performed a genome
re-annotation to improve the accuracy using a MAKER2-two-pass pipeline. To validate
the improvement a second pipeline, PEPA, was developed to compare quality metrics
between the old and new annotations. Approximately 1/3 of the original annotations from





         
 
   
   
   








genes using a diagnostic PCR protocol to differentiate between prior and new transcript
structures showed that over 80 % of tested genome locations supported for the new
annotation. Using rapamycin treatment to mimic stimulation of the vic response and
applying the RNA-seq and ChIP-seq data to this new information, we found that CPVIB-
1 is related to TOR signaling pathways, promoting autophagy and the proteasome
pathway, but repressing carbon metabolism, protein and lipid biosynthesis. In depth 
analysis of CPVIB-1-bound DNA targets showed that this protein is a member of the
GAGA regulator family, a group of multifaceted transcription factors with diverse roles
in gene activation and repression, maintenance of mitosis, and cell development. 
Following treatment with rapamycin the recognition sequence bound by CPBVIB-1 was 
altered leading to the regulation of different suite of genes with diverse metabolic
functions. Ultimately, we have developed a revised model of TOR signaling pathway 
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Cryphonectria parasitica causes chestnut blight.
Fungus C. parasitica
In 1906, William A. Murrill first reported a new fatal epidemic disease, chestnut
blight, of native American chestnut (Castanea dentata), which he observed in New York 
City, New Jersey, Maryland, the District of Columbia as well as Virginia [1; 2]. The pure
culture of the fungus causing the chestnut blight was obtained and isolated from the
infected chestnut twigs collected in the New York Botanical Garden [1]. The disease
starts from the fungus entering through a wound or dead limb of the tree and growing 
under the cortex in the layers of the inner bark and cambium. The symptom of the
infection in chestnut tree bark is a brown and soft canker with numerous yellowish-brown 
fruiting pustules called pycnidia containing massive amounts of spores[1]. Both the
asexual conidia and the sexual ascospores are able to be dispersed into fresh wounds of 
trees rapidly by wind and rain as well as transmitted by beetles and birds (Figure 1.1) [2;
3]. In time, depending on the size of the infected area, the fungus starts to form a canker 
around the infected spot, eventually girdling the stem or branch, leading to death [2]. 
Unfortunately, the mycelium of the fungus growing on the tree was found so active and 








   









In the Murrill’s report, the fungus was named Diaporthales parasitica, a sac fungi
species based on the observation of the mycelium and spore morphology in the life cycle. 
In 1978, based on the DNA sequence comparison and phylogenetic analysis, the chestnut
blight fungus was identified as one species of phylum ascomycetes, class
Sordariomycetes, order Diaporthales, and family Cryphonectriaceae and revised with a
worldly accepted new name Cryphonectria parasitica (Murr.) [4].
C. parasitica devastated the American chestnut Castanea dentata
American chestnut trees (Castanea dentata) were once dominant, the major 
hardwood trees in the forests of the eastern regions of the USA [5]. In the southern part of 
its range, American chestnut trees generally grew to 37 meters tall and 1.5 meters in 
diameter. Due to the wood being extremely hard and resistant to decay, the American 
chestnut was widely utilized for construction, furniture, railroad ties, musical instruments, 
and many other items [5]. The nuts used to be an important source of food for wildlife, 
domestic livestock, and humans. Furthermore, the tannins extracted from the bark and 
wood used to provide for the basis of a large tanning industry [4-6]. Since C. parasitica
was introduced into North American and spread rapidly, it devastated the American 
chestnut throughout its natural range by killing about 3.6 million hectares of American 
chestnut trees, an estimated loss of four billion stems, within 50 years (Figure 1.2) [5; 7-
8]. This filamentous fungus colonized in the wounded cambium of tree stems regardless
of the size, except the root systems that are protected in the soil. Root-collar sprouts
formed from the uninfected root systems allow the tree to start the asexual reproduction 
in the natural forests, but frequently become infected with blight fungus again [8], thus












   
 
   
      
  
  
    





   
existence of the sexual reproduction in nature leads to the functional extinction of the
American chestnut trees in the current forests [8].
Hypoviruses, a potential way to save American chestnut trees
C. parasitica was also reported in Europe in 1938, near Genova, Italy where the
fungus spread rapidly and caused the serious cankers on European chestnut trees as well
[9]. However, the damage caused by the fungus was found to have less severity in Europe
than in North America, leading to the discovery of the double strands RNA virus, 
Hypovirus [9]. In 1951, some healed cankers with the fungal mycelium only growing on 
the outer layers of the bark was discovered resulting in the chestnut trees survival from
the infection and this phenomenon was called hypovirulence [10]. Later, the hypovirulent
fungal strain was found to contain the high molecular weight double-stranded RNA
(dsRNA) leading to the white hypovirulence phenotype (Figure 1.3) [11].  Molecular 
characterizations have shown hypovirus lacks capsid structures [12]. The best
characterized type of hypoviruses, the CHV-1 family, have dsRNA approximately 12.7 
kb in length that contains two open reading frames (ORFs), ORF A encoding a papain-
like protease that generates two polypeptides p29 and p40, and ORF B encoding a similar 
protease p48 at amino-terminus (N-terminal) and containing regions of RNA-dependent
RNA polymerase (RdRp) and helicase (Hel) binding motifs, but with as yet undetermined
mature protein products [13-15]. It was found that the dsRNA was successfully 
transmitted to the virulent strains by converting them to hypovirulence through hyphal
anastomosis [16]. Since then, this chestnut blight fungus and its associated hypovirus
have been widely studied to provide a potential biocontrol strategy to restore the chestnut























Vegetative Incompatibility, limiting the transmission of hypoviruses among C. 
parasitica strains
In the United States, since 1975, the hypoviruses have been released into the
natural forests for the biological control of chestnut blight [18]. However, almost all these
efforts have resulted in the failure of transmitting the hypoviruses among the various
strains of C. parasitica [18]. The main factor that has received most attention is the
vegetative incompatibility system that restricts the hypovirus transmission between 
individuals. Vegetative incompatibility is a self/nonself-recognition system that results in 
the program cell death when cells of two incompatible individuals anastomose [19]. As a
defense mechanism of fungi, vegetative incompatibility is genetically regulated to trigger 
programmed cell death to prevent the mixing of cytoplasm of one individual with another 
during hyphal fusion when the horizontal transmission of hypoviruses can occur [20]. 
Vegetative incompatibility is a common phenomenon in the filamentous
ascomycete fungi. In model species Neurospora crassa and Podospora anserina, a few
genes that control this process were characterized at the molecular level [21]. 
Heterokaryon incompatibility (het) genes of the two species were characterized to encode
the proteins containing the conserved HET domain, which induces the recognition signal
and activates the programmed cell death process [22]. In C. parasitica, vegetative
incompatibility is controlled by at least six unlinked vegetative incompatibility loci (vic
loci), with two alleles at each locus [23]. Individuals are compatible if they share the
same alleles at all vic loci, but are incompatible if they differ at one or more locus. The
six unlinked vic loci (vic1, vic2, vic3, vic4, vic6, vic7) have been characterized through 
linkage mapping and comparative genomics [24]. Most of them contains the common 







     




    
   
 






     
  
   
 
activation of programmed cell death in vegetative incompatibility [20; 25]. At vic4, two 
alleles encoding a 359 amino acids protein kinase c-like and a 1,628 amino acids
NACHT/P-loop and WD40 repeats domains, respectively, were identified (vic4-1 and 
vic4-2) [24]. The two individuals differing at the vic4 (with vic4-1 and vic4-2 genotype
respectively) were found to form the barrage triggered by the above genes during 
anastomosis, but it was found not to impede the transmission of the hypovirus like the
other loci, and the mechanism of this phenomenon is still unclear [26].
CPVIB-1, a transcription factor that is essential for the vegetative incompatibility 
trigged by vic4
Transcription factors are a group of proteins that bind to specific DNA sequences
to mediate the expression levels of target gene in response to a signal [27]. There is a
class of p53-like transcription factors that is known as NDT80/PhoG-like DNA-binding 
family, the Ndt80 protein from Saccharomyces cerevisiae is one of the first members
found to bind to the middle sporulation element (MSE) to trigger the expression of 150 
genes during meiosis [28-29]. The number of NDT80-like genes in fungi are varied as
well as their roles, which include regulation of meiosis, sexual development, virulence
and the response to nutrient stress and programmed cell death [30-31]. 
In N. crassa, a mutant in an ORF named VIB-1 (vegetative incompatibility 
blocked) was found to suppress the phenotypic aspects of vegetative incompatibility 
trigged by the het-c locus [32]. VIB-1 was identified as a putative 670 amino acids
transcriptional factor due to its NDT80/PhoG-like coding domain, an ortholog of Ndt80 
gene of S. cerevisiae [33]. Later, VIB-1 was characterized to localize and aggregate in the







       
 
     
 
   
   
     
 
 
   
 
   
      
       
   
     
 
  
1 is essential for the expression of several genes involved in programmed cell death 
triggered by vegetative incompatibility, such as pin-c, het-6, and tol [32-33]. Further 
study suggested that CPVIB-1 functions as a regulator of hyphal compartmentation, death 
rates and conidiation in vegetative incompatibility as well as a repressor of glucose
metabolism [34].
In the chestnut blight fungus C. parasitica, an ortholog of VIB-1 of N. crassa, the
putative CPVIB-1 was identified by Rong Mu (unpublished study). CPVIB-1 was found 
to produce a protein of 649 amino acids in length, share 48% identity with VIB-1 of N.
crassa, and contain a NDT80/PhoG-like domain (unpublished study). In order to 
characterize the role of the CPVIB-1 such as vegetative incompatibility, virulence, 
hyphal growth, and the programmed cell death process, a cpvib-1 deletion strain was
generated. The cpvib-1 deletion strain was observed with phenotype shifting in various
aspects, including virulence, hyphal growth, sporulation, and vegetative incompatibility 
regulation.
The Dcpvib-1 mutant strain shows reduced hyphal extension and profuse conidiation, 
indicating CPVIB-1 is required for fungal cell growth and to regulate the signals
controlling sporulation (Figure 1.5). The deletion of cpvib-1 largely decreasing the canker 
formation on the chestnut stems indicates that CPVIB-1 plays a direct or indirect role in
virulence (Figure 1.6 (A)). Statistical analysis shows the canker size of the ∆cpvib-1
strain is significantly smaller compared to both EP155 wild type (WT) strain and its
hypovirus-infected strain (Figure 1.6 (B)). Also, the deletion of cpvib-1 alters the barrage
formation pattern between EU1 and EP155 strain, which differ from each other in the




     
  

















(Figure 1.7 (A)) but disappeared when cpvib-1 was disrupted from both sides (Figure 1.7 
(B)) implying that CPVIB-1 is required for the barrage formation in vegetative
incompatibility triggered by vic4 (unpublished study, R. Mu).
In conclusion, consistent with the roles of VIB-1 in N. crassa, CPVIB-1 in C. 
parasitica is crucial for vegetative incompatibility triggered by at least one allelic 
mismatch, hyphal growth, sporulation, and pathogenesis.  
The goal of this project
The primary objective of this study is to identify the direct and indirect targets of 
CPVIB-1 in C. parasitica to further build the complete pathway for the vegetative
incompatibility system. As a transcription factor with a NDT80/PhoG like domain, 
CPVIB-1is hypothesized to bind specifc DNA sites in the genome to activate or repress
the transcription of its targeted genes, which then affect their downstream factors. We
propose two strategies to achieve the goal. The first strategy is the large scale
transcriptome sequencing (RNA-Seq) of the EP155 wild type and its isogenic Dcpvib-1
strain. Transcriptome comparison analysis is the critical step to provide the informative
insights into the downstream effectors of CPVIB-1 with the well accepted bioinformatics
pipeline and reliable genome reference.  The second, more challenging, stategy is to 
identify the exact binding locations of CPVIB-1 by using ChIP-Seq (Chromatin 
Immunoprecipitation and Sequencing). This will use a tagged CPVIB-1 protein 
containing the FLAG peptide, cross-link it with its bound DNA, fragment the DNA, then 
immunoprecipitate the protein-DNA complex with specific antibodies to recover the
DNA fragments bound to the CPVIB-1 protein, prior to sequencing the bound sites using 

















   
 
 
transcriptome comparison analysis and ChIP-Seq analysis was the availability of an 
accurate and reliable genome reference and annotation, which brings up the second 
objective of this study.
The second objective of this study became a re-annotation of the C. parasitica
genome with improved accuracy and enriched structual and functional information. 
Using outdated bioinformatics tools, the shortage of transcripts evidence (ESTs from
Sanger sequences), and the discovery of mistakenly annotated genes (Willyerd, et al.
unpublished data), the prior genome annotation (2009-version) from JGI (Joint Genome
Institute) was hypothesized to be in a poor condition with misannotated gene models
structurally and functionally. The general existence of the inaccurately predicted gene
models could impact studies to identify specific functional genes as well as studies of 
revealing the regulation mechanisms using genome scale strategies. We therefore set out
to re-annotate the genome of C. parasitica with the advanced MAKER2-two-pass
pipeline to generate gene models to train the predictors and provide the quality metrics
system, the RNA-Seq data to provide sufficient transcripts evidence, and the newly 
UniProt/SwissProt protein database to provide more experimentally reviewed protein 
evidence. With this re-annotated version (2017-version), the first objective of this study 
was carried out relying on this improved annotation to provide more accurate and 
informative results.  However, with both the prior annotation and the re-annotated version 
available, it was necessary to carry out a comparison between them to report their 
differences in structural and functional predictions and their accuracy as well, which 















The third objective of this study was to develop a pipeline to evaluate the prior 
annotation of C. parasitica and compare it to the re-annotated version with the purpose of 
evaluating each of the gene predictions, and finally sort them into four categories
corresponding to their accuracy and consistency between the annotations. 
In summary, this study began with investigations of the vegetative incompatibility 
pathway of C. parasitica using newly available high throughput transcriptome and ChIP-
Seq technologies. Fulfillment of those goals also necessitated re-annotating and 
validating gene model predictions in order to be confident that the results of our studies
would be as accurate as possible. As a beneficial by-product of this work, we have
developed a novel pipeline for genome annotation comparisons that is broadly applicable
to other experimental systems, and also greatly improved the accuracy of genome














Figure 1.1 Infection cycle of C. parasitica in American chestnut trees based on 
information read in reference [3].
The mycelium in the infected canker region is able to produce conidia with asexual
reproduction process as well as ascospores with sexual reproduction process by mating 
with spores from other strains. Both conidia and ascospores are able to enter fresh 
wounds in another American chestnut tree by the dispersion of vectors, such as wind, 
rain, and insects and germinate to orange mycelium leading to the formation of the







   
   
  
  
Figure 1.2 The natural range of American chestnut trees [8].
The gray shaded area represents the natural range of American chestnut populations; the





                                                 











Figure 1.3 The phenotype comparison of the two representative C. parasitica strains.
(A) represents the phenotype of EP155 wild type strain without hypovirus infection, (B) 







   
  
    






Figure 1.4 Vegetative incompatibility (vic) assay displaying the compatible and 
incompatible phenotypes [24].
The bottom image represents the incompatible phenotype with a red arrow pointing to the
barrage lines (a line of dead cells) that forms when two individuals that differ at one or 
more vic locus merge and trigger the programmed cell death. 





   
      
   





Figure 1.5 CPVIB-1 regulates sporulation and aerial hyphal growth [35].
(A) Morphological phenotype representatives of the cpvib-1 deletion, complementary and
overexpression mutants (∆cpvib-1, OECPVIB-1-∆cpvib-1, OECPVIB-1-EP155) as 
compared to the EP155 wild type strain when grown on petri plates. Sporulation and 
aerial hyphal growth patterns were shown under each strain. ∆cpvib-1 strain produces
profuse spores and reduced aerial hyphal growth compared to EP155 strain. (B) 
Quantitative analysis of sporulation using individual median test to determine pairwise












Figure 1.6 CPVIB-1 is important for fungal pathogenicity[35]. 
(A) Representative virulence assays on dormant chestnut stems carried out for 28 days.
Canker sizes were labeled with red lines for each strain. (B) Graphical representation of 
the virulence assay using individual median test to determine pairwise differences with 
three biological replicates. Levels not connected by the same letter are significantly 














Figure 1.7 CPVIB-1 is involved in vegetative incompatibility [35].
(A) EP155 (WT) demonstrating incompatibility with EU1 but compatibility to EU5. (B) 
Deletion of cpvib-1 from both EP155 and EU1 and EU5 changes the compatibility 

















   
 
RE-ANNOTATION OF THE GENOME OF CRYPHONECTRIA PARASITICA
Abstract
Next generation sequencing (NGS) technologies create great opportunities for 
various genomics, transcriptomics and proteomics projects of exotic non-model
organisms. A well-annotated genome reference is critical for these projects like exploring 
target genes’ functions or characterizing gene expression profiles.  However, the errors in 
the annotation are often present in existing databases such as NCBI and JGI because of 
the lack of supporting evidence. Now, for exotic organisms, having the assembled 
genomes, detailed transcript evidence from RNA-Seq and more recent curated proteins
database available, provides opportunities to perform a better quality new genome
annotation or an improved re-annotation. Therefore, a practical MAKER2-two-pass
pipeline was designed to perform a re-annotation of the genome of C. parasitica. This
resulted in 11,171 predicted gene models, with 92% of them having coding domains
matching various databases, and 78.36% of them having at least one conserved domain 
and important coding sites with an InterPro ID. The re-annotation provided new
structural and functional features including, mRNA, UTRs and quality metrics system
and ortholog proteins names, conserved domain IDs, and GO terms (Gene Ontology 
terms), separately. Together, these results suggested that the re-annotation provides an 





   
    
 
 
   
 
    
 
 






     
 
Introduction
Next generation sequencing (NGS) techniques have dramatically dropped the
costs of genome sequencing projects leading to unprecedented opportunities for many 
non-model organisms’ genome projects [36]. At the time of writing, 5,386 eukaryotes
genome sequences are recorded in NCBI genomes database with “scaffold or contigs”
and “Chromosomes” status, indicating those are at the amenable stage for gene and 
genome annotation. 
Most recent gene predictors for annotation were built based on the Hidden 
Markov Model (HMM), which defines probability distributions statistically for sections
of genomic sequences in eukaryotes, like introns, exons, untranslated regions (UTRs), 
etc. [37]. The accuracy of gene prediction with the above tools mainly depends on the
amount of evidence to pinpoint boundaries between each two states, such as intron-exon 
boundaries or UTR-exon boundaries[38].
Yet, in many ways, the genome annotation for non-model organisms has
encountered a lot of challenges. One of the factors responsible for this is the absence of 
sufficiently large and reliable experimental evidence for the gene finder algorithms. 
Second is the lack of pre-existing gene models like the first generation of genome
projects with relatively large resources [39]. 
By investigating gene expression profiles using RNA-Seq data aligned to a 
reference genome [40], the advance of NGS technologies and the corresponding 
bioinformatics tools have allowed more and more non-model organisms to have





    
       
 










   
 
explored. However, there are many challenges in obtaining the reliable results from such 
projects especially given the lack of a high-quality genome annotation.  
The genome project of the C. parasitica was carried out in 2009 using 
predominantly Sanger sequencing technology, and along with its first version of gene
predictions, was released by the Joint Genome Institute (JGI). Although this was a
significant advance at the time, the bioinformatics tools used, and the lack of quality 
metrics, have made this information outdated. Contributing to this problem were the use
of low coverage expressed sequence tags (ESTs), a then current (but now outdated)
proteins database, and the fact that there were only 15 gene models of C. parasitica
reviewed in Swiss-Prot database with experimental evidence. Considering these factors, it
is no surprise that there are mistakenly annotated gene models structurally and 
functionally in the first annotation version of C. parasitica. 
While it is not feasible for any genome annotation, to be 100 % accurate, 
inaccurately predicted gene models have the potential to impact the studies of functional
genes and domains of interest that relate to all aspects of the organism’s biology. Before
the work performed for this study, there were at least four genes on different scaffolds of 
the C. parasitica Ep155 assembled genome that were identified as not matching the
predictions from the first annotation (2009-version).  Three of them were transcribed in 
different regions and one was found with different reading frame (Willyerd, Pokharel, 
Ren and Dawe, unpublished observations). 
Furthermore, our initial transcriptome profiling project using knock-out strains for 






     
   
   
   
  
   
 
  





   
  
   
  
 
   
  
 
these errors found in the C. parasitica Ep155 strain are common for a genome project of 
its age with insufficient evidence, annotation tools and strategy [41-42]. 
Fortunately, the NGS high-throughput RNA-Seq technique offers an enormous
amount of assembled transcript data to help predict new genes and transcripts [41-42].
Out of all forms of evidence, high quality RNA-Seq assembled transcriptome sequences
have the greatest potential to improve the accuracy of gene annotations, as these data
provide copious evidence for better delimitation of exons, splice sites and alternatively
spliced exons [39]. Compared to first-generation sequencing, NGS could generate more
than 500 gigabases in a single run creating a great opportunity to improve annotation 
quality and reveal each transcript with high coverage, high sensitivity and high dynamic
range [43].
In this study, we proposed to re-annotate the genome of C. parasitica taking 
advantage of more transcript evidence from the NGS transcriptome sequencing (RNA-
Seq) and the newly updated protein evidence from the UniProt/SwissProt database
consisting of all manually annotated and reviewed proteins. The Illumina HiSeq2500 
platform was used to sequence three samples of the transcriptome from the C. parasitica
Ep155 strain in the 100bp pair end mode. Each sample library yielded between 45 and 51
million 100 bp reads for a total of about 21 Giga bases of sequence data. With the
abundant RNA-Seq data, the genome reference based transcriptome assembly was in 
order to provide assembled transcript evidence to the re-annotation process using the
widely accepted Tophat and Cufflinks Tuxedo suite pipeline [44].
The second advantage of this study was to use the advanced MAKER2-two-pass







     
  





   
 
   
     
     
         
      
   
 
pipeline incorporating three gene predictors, GeneMark-ES, SNAP and Augustus[38; 45-
48]. 
An important feature of this pipeline is GeneMark-ES-3.0, a self-training gene
predictor employing an unsupervised training procedure to produce a reliable ab initio
gene model training sets for subsequent gene finder methods, SNAP and Augustus [47]. 
Then, the HMM based gene finder Augustus was used to find an optimal parse of a given 
genomic sequence. The advantage of using SNAP is to allow for both change of the
underlying HMM and flexible inputs from the above steps, resulting in iteratively 
improved training sets with transcriptome and protein evidence [45; 49-50]. MAKER2 is
an annotation management tool that combines all three of the above gene predictors along 
with built-in tools, including RepeatMasker, BLAST+, and Exonerate. It provides an 
easy-to-use way to either perform a de novo genome annotation with a new genome, or 
update a pre-existing annotation with quality-control metrics, by aligning protein and 
RNA evidence in a splice-aware manner to accurately identify splice sites [45].
The resulting C. parasitica genome re-annotation provides more accurate and 
informative predicted gene models than the prior annotation (2009-version). New
structural and functional features as well as quality metrics system for each predicted gene
model were generated in this study based on more evidence and better tools. Overall, this
new annotation, named 2017-version, provided an improved annotation file and facilitates











   
    
 
  










     
Materials and Methods
Fungal transcriptome preparation and RNA-sequencing 
Mycelia of C. parasitica’s wild type strain EP155 were cultured in potato 
dextrose broth (PDB; Difco, Sparks, MD) on the benchtop under ambient conditions. The
cultures were homogenized and diluted with fresh media (1:1 volume) and allowed to 
grow for an additional 16-18 hours to achieve log phase fungal cells for RNA extraction. 
Following harvesting by filtration through Miracloth, the cultures were then immediately 
ground to a fine powder by using a sterilized mortar and pestle with liquid nitrogen [51]. 
Total RNA was then isolated from about 30 mg powered mycelia using RNeasy® mini
kit (Qiagen) according to the manufacturers protocol. Next, the quality of the total RNA
was determined by agarose gel and analysis on an Agilent 2100 Bioanalyzer®
(www.chem.agilent.com). Briefly, 1 µg total RNA with a RNA integrity number (RIN) of 
8 or higher was enriched for mRNA using Illumina TruSeq RNA sample preparation Kit
v2, Set B (Illumina, #RS-122-2001) according to manufacturer’s instruction. Next, the
Bioanalyzer was used to detect size distribution of the transcriptome after fragmentation 
and adapter ligation, and a Qubit® Fluorometer (InvitrogenTM, Waltham, MA) was used 
to quantify the yield post-PCR amplification. Finally, the pooled cDNA libraries with 10 
µM concentration from each sample were sequenced on Illumina HiSeq2500 platform in 
a 2 x 100bp paired-end (PE) configuration with High Output mode (V4 chemistry) at 
Genewiz (South Plainfield, NJ).
Reference based transcriptome assembly
A python pipeline script was written to perform one-step transcriptome assembly 




    
   
  
  
   
 
   
  
    
  
 
    
    
 
   





    
   
    
above by using the open source software programs of the Tuxedo suite and other
auxiliary programs (Figure 2.1) [52]. First, a widely applied quality assessment software
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to exam
the quality of the reads, which indicated no need for any trimming process. All 
sequencing files were then aligned to C. parasitica reference genome from JGI 
MycoCosm genome portal (http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html)
with Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml) and TopHat
(https://ccb.jhu.edu/software/tophat/index.shtml) to discover transcripts splice sites, using 
default parameters [44]. Subsequently, Cufflinks was utilized to assemble the transcripts
from all successfully aligned reads of each sample, followed with running Cuffmerge to 
merge their assemblies together into an integrated reference transcriptome annotation file
[ 42; 44; 52]. The python script file Transcritpome.assemble.pipeline.py is available from
the GitHub website (https://github.com/didiren/transcriptome_assembly) and can be
applied to run one-step transcriptome assembly in any system with Bowtie2, TopHat, 
Cufflinks and Python available [42; 52]. A README.md file has been included to 
demonstrate the usage of this pipeline starting with the raw RNA-Seq FASTQ files. The
output generated was a file called Assembled_transcriptome.fasta that was then used for 
genome annotation in the next section.
MAKER2-two-pass genome annotation pipeline
The MAKER2-two-pass genome annotation strategy used in this study required 
three input files for this pipeline: the assembled C. parasitica genome file; the newly 
generated assembled transcriptome file; and, the well-characterized protein dataset




      
   
   
 
     
     
         
   
 
    
     
    
    
 
   
   
  
       
  
      
    
provided the intrinsic RNA evidence and the extrinsic protein evidence to improve the
gene model prediction (Figure 2.2).
RepeatMasker was used to identify the repeats regions in conjunction with the
compacted repeat libraries RepBase in MAKER2 package by taking all libraries as
resource (Figure 2.2) [39]. Subsequently, GeneMark-ES-3.0, a self-training gene finder 
that can identify protein-coding genes, was run to creates the ab initio HMM gene models
from the genome file only [56]. Next, the gene model predicted above was applied to the
MAKER2-first pass annotation process to train its installed gene-predictors, SNAP and 
AUGUSTUS, as well as experimental evidence of exon-intron boundaries from
transcriptome assembly and the protein dataset to improve the accuracy of gene
prediction [23; 38; 46; 57; 58]. Because of the iterative fashion of MAKER2, the gene
prediction process can achieve higher accuracies by running the MAKER2 a second time 
using the gene models built from the first pass as training data [45; 48; 59]. At the end of 
the second run, MAKER2 consolidated the output to a final annotation in GFF3 format
(called 2017-version) by picking the post-processed gene models that were most
consistent with the experimental evidence such as RNA and proteins alignments [39; 45;
59]. Along with the annotation file, the gene, transcript, CDS and protein sequences for 
the predicted final gene model were extracted in FASTA format. Although the structural
predictions of the gene model are complete at this point, it is essential to assign putative
gene functions to newly annotated genes. In order to build these annotations, the
reviewed proteins dataset from UniProt/Swiss-Prot was used as reference to append the
matching protein’s name to each predicted gene model in the GFF3 file using BLASTp. 













     
   
   
  
  
    
were appended to the predicted gene models using InterProScan [60-62]. The detail for 
the above operations are illustrated in https://github.com/didiren/PEPA. 
Results
Description of C. parasitica genome
The first step towards the successful annotation of any genome is a good genome
assembly [39]. The Ep155 strain of C. parasitica used in this study is the laboratory-
standard well-characterized, virulent strain (ATCC 38755) [63]. The latest genome
assembly was completed with 26 main genome scaffolds in a size of 43.9 Mb by 
constructing the whole genome shotgun reads in 2010. Assembly parameters are reported 
by JGI as follows: Scaffold N50 is 5,118,729 bp, the estimated gap percent is 0.2%, and 
the coverage of genome is 99.6 % 
(http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html).
Quality assessment of the RNA-Seq reads
The transcriptomes of three biological replicates of Ep155 strain generated 147.7 
million reads for three libraries with the average mean quality scores of 35.57 to 35.71 
and >=Q30 scores of 94.07 % to 94.53 % (Table 2.1). Generally, sequence runs with >50
% of the nucleotides having quality scores >Q30 are considered acceptable [64]. 
Therefore, 35.65 as the mean quality score of the three libraries combined, and >94% 
bases per read with a quality score >Q30, indicated the high quality of the sequences











    







   
 




Quality assessment of the transcriptome assembly
94.2 % to 95.1 % of the reads from the three samples were mapped to the
reference genome, with 93 % of the reads being concordant from paired files of one
sample (Table 2.2). This compares favorably with expected sequencing accuracy, given 
that 70 – 90 % of RNA-Seq reads from humans samples are expected to map onto the
humans genome [65]. In order to improve annotation with the new transcripts evidence, 
the transcriptome assembly was performed without using the prior annotation as
reference to reveal novel transcripts [65]. There were 12,926 to 13,037 novel transcripts
in each transcriptome as defined by Cufflinks in General Transfer Format (GTF) format, 
and Cuffmerge united three of them to 14,707 novel transcripts for C. parasitica genome
(Table 2.2). 
New structural and functional features in the re-annotated version
Compared to the prior annotation file from JGI additional gene structures, such as
mRNA, exon, coding sequences (CDS), 3’UTR and 5’UTR, were listed for each 
predicted gene. Also, quality metrics, including MAKER mRNA Quality Index (QI) tags
and the Annotation Edit Distance (AED) scores, were added to each predicted gene
model in light of new transcript and protein evidence. AED is a measure of the agreement
between each predicted gene model and its supporting evidence, with a number between 
0 and 1. An AED score of 0 denotes a perfect prediction with clear supporting evidence, 
while a value of 1 indicates a complete absence of evidence supporting the annotated 
gene model [59]. In addition, the predicted protein’s name from UniProt/SwissProt
dataset as well as the conserved domain information, such as InterPro ID, Pfam ID and 





















Optimum predicted gene models from the MAKER2-two-pass pipeline
There were 8,278 gene models predicted in MAKER2-first pass preliminary 
annotation step and 11,171 genes models after the completion of MAKER2-second pass
final annotation while using the full strategy (Table 2.4) (Figure 2.2). In contrast, only 
7,419 and 7,272 predicted gene models were discovered without applying the ab initio
gene predictor GeneMark-ES (Table 2.4) (Figure 2.2). 
A previous study reported that a well annotated proteome would mean that 55 to 
65 % of the predicted proteins should contain a recognizable domain [45; 48]. For these
11,171 predicted gene models, 10,285 (92 %) of them have hits from at least one domain 
database (such as CDD, Gene3D, Hamap, PATHER, Pfam, SMART), and of those 8,059 
(78.36 %) have clear conserved domains and important coding sites with the InterPro IDs
and GO IDs. This provides additional supporting evidence as to the effectiveness and 
accuracy of this new annotation.
Discussion
The accuracy and completeness of a genome annotation directly impacts the
validity of individual gene or genetics-based functional studies [66]. During a study to 
identify potential virulence effectors and downstream factors of related transcriptional
regulators in C. parasitica, the prior annotation (2009-version) resulted in miss-steps due
to the mistakenly predicted gene models. It is especially critical for plant pathology, for 
which extensive research efforts have been invested into identifying and characterizing 
putative virulence-associated effectors to contribute to the control of disease and the























As mentioned above, the first step towards a successful genome annotation is to 
conduct an assessment of its genome assembly to describe its completeness and 
continuity with a N50 score, which is the most widely used statistics for describing the
genome assembly quality [39]. Therefore, the N50 scaffold length of the C. parasitica
genome equals to 5,118,729 bp indicates a high-quality genome assembly.  Two other 
informative statistical parameters reflecting the quality of genome assembly are the
percentage of gaps and the coverage of genome [39]. In this case, these values are 0.2 % 
and 99.6 %, respectively. Thus, the C. parasitica genome assembly obtained from Sanger 
sequencing was demonstrated to be a remarkably high-quality product.
When re-annotating this genome, the transcriptome assembly was generated from
approximately 146 million 100bp mRNA reads, which have a mean quality score of 
above 35 (25 is considered decent score in NGS). Moreover, more than 94% of reads
were aligned to the genome assembly leading to more than 300-fold increased coverage
of the transcriptome in C. parasitica. The Tuxedo suite pipeline generated a large set of 
transcripts models, many of them overlapping one another. The final transcriptome
assembly comprised 14,707 transcripts. This represented about 3,000 more novel
transcripts and about 650bp longer average transcript length compared to the prior 
annotation (2009-verion). 
In addition to new transcript evidence, the protein evidence was used in this study 
is from UniProtKB/SwissProt database, which has been highly recommended as an 
excellent core source of curated proteins [53]. This is the recommended database to use
when working with an organism that has a limited number of reviewed proteins (such as














    
  
 
In the prior annotation, the bioinformatics tools were only capable of finding the
most-likely CDS of a gene but did not report UTRs or alternative spliced variants. The
MAKER2-two-pass pipeline for the genome annotation provides a much more complex 
output than simple gene prediction. It not only reports the CDS, exon and gene structural
features based on the heterogeneous evidence, but also synthesizes gene models and 
produces an output that describes detailed features such as 5’UTRs, 3’UTRs, exon and 
mRNA, which can be visualized in genome browsers and annotation databases. Secondly, 
MAKER2 is the first bioinformatics tool to provide a quality metrics system. MAKER2 
mRNA Quality index (QI) tags and the Annotation Edit Distance (AED) scores are
included in the annotation process. Thus, the quality assessment provided a means to 
highlight any problematic predicted gene models for further manual curation and also 
gave a measure for the comparison of two annotation versions. The third feature in the re-
annotation version is the functional addition to each predicted gene model of a conserved 
domain ID, GO ID and protein name from the UniProtKB/SwissProt database. With the
addition of the three new features to the annotation it provided both more accurate
predicted gene models and increased confidence in the information presented.
The overall quality assessment of an annotation has been suggested to consider 
three factors: the number of predicted gene models; the protein domain content; and, the
AED scores. In this study, as a non-model organism, C. parasitica does not have a pre-
existing gene model to train the gene predictors. The MAKER2-two-pass pipeline took 
the advantage of the specific self-training gene predictor, GeneMark-ES to provide a
training gene model and iteratively improve the prediction quality resulting in 11,171 




















the model fungus, N. crassa, has about 10,000 protein coding genes in approximately 40 
million bp size genome (http://fungi.ensembl.org/Neurospora_crassa/Info/Index). 
Therefore, the total gene number in the re-annotation is similar compared to other related 
organisms. Secondly, 92 % of the predicted gene models (2017-version) have at least one
coding domain, more than the 55 – 65 % usually considered to represent a high-quality 
annotation [59]. The third factor, AED scores, will be described in detail in Chapter 3. 
In conclusion, the genome of C. parasitica was sequenced, annotated, and 
released in 2009 using the technology and tools available at that time. However, with 
deep transcriptome sequencing and updated protein evidence, re-annotation is now more
accurate and informative. This improved genome annotation provides a valuable resource
for researchers who are interested in both comparative and functional studies of C. 
parasitica. The integrated annotation analysis by applying the MAKER2-two-pass
pipeline has facilitated the improvement of the genome annotation and this approach can 





       
 
 
   
    
    



















Table 2.1 RNA-Seq read quality from three biological replicates of the C. parasitica
Ep155 strain.
Sample Reads Yield *% of >= Q30 Mean Quality 
(Million) Bases Score
EP155s1 51.94 94.37 35.57
EP155s2 45.44 94.53 35.68
EP155s3 50.34 94.07 35.71
*% of >= Q30 Bases means the percentage of all baes in a read containing no more than 




















   
 
   
     
   
   
 




















Table 2.2 The quality of read alignments and transcriptome assembly.
Sample Read Yield Read number aConcordant pair bDiscordant Transcript Total
(Million) mapped to alignment rate alignments rate Counts TranscriptCounts
genome (Cufflinks) (Cuffmerge)
EP155s1 51.94 49.88 M 94.2% 0.3% 13,037
(96.1%)
EP155s2 45.44 43.86 M 94.7% 0.3% 12,926 14,707(96.5%)
EP155s3 50.34 48.92 M 95.1% 0.5% 13,010
(97.2%)
a Concordant pair alignment rate, referring to the percentage of reads from both paired-
end sequencing file matched to the same locus in the genome. 
b Discordant alignment rate, referring to the percentage of reads from both paired-end 









































Table 2.3 New structural and functional features in the re-annotated version 
compared to the prior annotation. 







Functional None * Ortholog proteins name from UniProt/SwissProt
features InterPro domain ID
GO ID
Extra domain databases ID
* indicates there are no functional features attached in the prior GTF annotation file, but
the JGI website has protein names, domain ID and GO ID for each predicted gene model
































Table 2.4 Comparison of the predicted gene model when applying the different
strategy of MAKER2-two-pass pipeline.
Predicted gene models number
Use the first passa Use two-passa, b 
With GeneMark-ES (cRed) 8,278 11,171
Without GeneMark-ES 7,491 7,272
(cRed)
a referred to the steps highlighted in blue in MAEKR2 two-pass pipeline. b referred to the
process highlighted in green in MAEKR2 two-pass pipeline. c referred to the process





     
   
  
   
    









Figure 2.1 Transcriptome assembly Tuxedo suite pipeline strategy.
All RNA-Seq fastq files were fed into this Tuxedo suite pipeline with the beginning step 
of quality examination by FastQC. Trimming process was optional based on the quality 
of the reads from the former step. Then, the alignment was performed against the
reference genome using TopHat, the transcripts were assembled individually with 



















Figure 2.2 MAKER2-two-pass genome annotation strategy.
(A) The strategy started from the prerequisite RepeatMasker included in MAKER2, then 
in the MAKER2-first pass, an external gene predictor GeneMark-ES highlighted in red 
were used to provide a training HMM file along with the RNA and proteins evidence for 
the second pass gene predictors, showing a significant improvement in the number of 
predicted genes. (B) In the MAKER2-second pass, the gene models generated above
were applied to train the other gene predictors, SNAP and Augustus along with 





   
 
 
    










PEPA: A PIPELINE TO COMPREHENSIVELY EVALUATE A PRIOR GENOME 
ANNOTATION AGAINST A NEWER VERSION
Abstract
For the non-model organisms, a well-annotated genome reference is critical for
either exploring single target gene function or characterizing whole genome expression 
profiles. Recently, some integrated genome annotation pipelines were developed to 
combine the evidence of abundant transcripts and the improved protein evidence to 
increase the performance of genome annotation. However, in terms of all target genes
predicted and annotated from a prior and potentially outdated genome annotation, it is
essential to evaluate the accuracy and discrepancy compared to the newer version. In the
case of C. parasitica a simple pipeline, PEPA, was developed to comprehensively 
estimate the accuracy of each prior predicted gene model (2009-version) with updated 
transcript and protein evidence using the MAKER2 legacy annotation program, and 
thereby enrich the gene models with a quality metrics system and internal domain
information (InterPro ID). Subsequently, a comparison of the prediction quality of all
gene models from the prior annotation (2009-version) and the re-annotation (2017-
version) from above was carried out. A python script was developed to sort each 
individual gene model from the prior genome annotation (2009-version) into four 















    
 
 
version (2017-version)). Twenty-seven of the predicted gene models comprising 
representatives from the Similar, Different and Noexist categories were then 
experimentally validated using a diagnostic PCR design to amplify the distinct regions to 
differentiate between the possible mRNA products predicted by the different annotation 
results. Of 11,609 predicted gene models from the 2009-version, only eight (0.06 %) 
were completely supported with transcript and SwissProt protein evidence. 
When the two annotations were compared using the PEPA pipeline, 32.73% of 
predicted gene models were sorted into the Match category, 33.19% into the Similar 
category, 30.84% into the Different category and 1.1% into the Noexist category. 
Subsequently, 22 out of 27 chosen predicted gene models (from 2009-version) were then 
experimentally proven by PCR to support the re-annotation. Altogether, the results
showed the general existence of errors in the 2009 annotation and the applicability of the
PEPA evaluation pipeline in identifying the potential mistakenly predicted gene models
to any genome annotation project. 
Introduction
NGS encourages researchers to obtain the genome sequence of the exotic, non-
model, organisms rapidly and with relatively low cost. Consequently, the accumulation of 
the genome annotations is rapidly increasing but they are mainly accomplished with 
automated annotation systems rather than something with more manual input as can be
accomplished for model organisms supported by large research communities [69-70]. 
Many institutes, such as Joint Genome Institute [71] and University of Maryland’s IGS
(Institute for Genome Sciences) annotation engine














    
 
 
systems for various genome projects of bacteria and fungi. However, a reality of using 
automated annotation systems is the existence of errors in the output annotation, which 
can mislead future work. Also, when annotated once, these projects may not be updated 
to take advantage of the most recent tools and databases available to improve the
annotation. 
For the same set of genome data different annotation systems may generate
different results based on their various methods [72]. However, it is difficult to decide
which one is more suitable and accurate without comparing them, since a universal
standard is not available. Therefore, quality control is the significant issue for all genome
annotation projects. 
The definition of genome annotation generally refers to the structural and 
functional annotation [39]. The approach for testing the quality of the structural
annotation is to establish the quality metrics that measure the consistency of each 
annotation with its overlapping evidence, such as protein and transcriptomic data [39]. 
One example of a quality metrics system that was developed by Sequence Ontology 
Projects is the Annotation Edit Distance (AED). This was applied in an integrated 
annotation pipeline, MAKER2, which is able to automatically calculate AED for each 
predicted gene model [39; 73].
Considering the impact of potentially incorrect gene model predictions on further 
studies of charactering individual target genes and also genome scale expression profiles, 
re-evaluating genome annotation projects that were prepared without any quality metric







   
   
 




   
  
 




Here, PEPA uses MAKER2 to not only carry out a re-annotation utilizing new
mRNA-Seq data and updated protein data to improve annotation quality, but also to add 
quality metrics like AED to a legacy-annotation [48].
Then, PEPA will evaluate the prior genome annotation, regardless of the format, 
against a newer version to illustrate the structural and functional differences of each gene
model and its accuracy and sort each predicted gene model into four categories (Match, 
Similar, Different, Noexist) based on discrepancy between the structural (start/end 
coordinates) and functional (coding domain InterPro ID) information compared to the
same predicted gene model from the newer version. 
To test the efficacy of this approach, we used the most recently released genome
annotation of C. parasitica from 2009, publicly available from the USDA Joint Genome
Institute (JGI; http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html). Both the
quality metrics AED system and conserved coding domain InterPro ID were appended to 
this legacy data. Following this process for C. parasitica, we found that only 
approximately 1/3 of the original predicted genes were considered the same in both 
annotations. Furthermore, when tested individually by diagnostic PCR, 81.5 % of a
selection of different annotations supported the newer version.
This evaluation pipeline of a prior genome annotation has major implications for 
future work by providing reliable insights of each predicted gene model with the new
quality metrics and identifying which specific gene predictions may be problematic. 
Especially in non-model organisms, using more efficient and accurate results with 





















     
    
  
model is extremely important for future characterization by specific studies and also for 
large scale transcriptomics data analysis.
Materials and Methods
Transcriptome evidence and protein evidence
The same transcriptome and protein evidence were used here as described in the
Materials and Methods of Chapter II.
MAKER2 legacy protocol
Like the MAKER2-two-pass pipeline described in the Materials and Methods of Chapter 
II, MAKER2 legacy annotation protocol provided the means for employing the transcript
and protein evidence to train its installed gene finders to evaluate the accuracy of the
prior genome annotation. The details for this operation are illustrated in the
README.md file available in https://github.com/didiren/PEPA.
InterProScan protocol
The same tool and protocol was used here as described in the Materials and 
Methods of Chapter II. The commands for this operation are illustrated in 
https://github.com/didiren/PEPA.
Visualizing the quality distribution comparison of legacy annotation and re-
annotation version
An R script was developed to visualize the qualities of the predicted gene models
at the genome-level by displaying the cumulative distribution of AED scores [59]. This R





















Sorting genes predictions from the prior annotation by their discrepancies against 
the re-annotation
A custom python script was developed to sort each predicted gene model from the
prior version to four categories, Match, Similar, Different, and Noexist, based on the
discrepancies of coding regions (start/end coordinates) and coding domains (InterPro ID) 
against the newer version (Figure 3.1). The script ultimately generated a text file for each 
category with the gene model ID, the coordinates, the AED scores and the protein 
ortholog names from both annotation versions attached. If the predicted gene models
from the prior annotation shared the exact same coordinates for their CDS with the newer 
version, they were sorted to the Match category (Figure 3.1). If their CDS coordinates
were different but their transcript coordinates overlapped with the newer version gene
models and they shared the same conserved InterPro domain ID, they were sorted to the
Similar category (Figure 3.1). Thus, the Different category included those predicted gene
models from the prior annotation that shared different conserved InterPro domain ID in
addition to overlapped transcript coordinates with the newer version (Figure 3.1). The last
category, Noexist, contained the predicted genes from the prior annotation that were not
predicted to be present in the newer version as well as any that were not supported by any 
RNA evidence (Figure 3.1). This python scripts file named PEPA.py is available in my 
GitHub website (https://github.com/didiren/PEPA.git). The README.md file
demonstrates the usage of this script starting with two annotation files as well as the






       
      
   
     
    
   









    
Validation of 27 predicted genes from the prior annotation showing discrepancies
with the re-annotated prediction
There were 27 genes in total, seven from the Similar category, six from the
Noexist category and 14 from the Different category chosen to experimentally validate
the quality of the newer annotation. For each, the specific primers were designed based 
on the distinct region of their predicted transcript from the two annotation versions.
Polymerase chain reaction (PCR) was used to amplify those regions from both cDNA and 
genomic DNA. All the products were viewed on a 1% (w/v) agarose gel to examine the
accuracy of each prediction. Selected genes and their primers are listed in Appendix A
chapter. 
Results
The quality comparison of the predicted gene models from the prior and newer
annotation version
As one of the two important factors to evaluate a genome annotation, the quality 
metrics AED scores cumulative distribution curves were displayed for each annotation 
set (Figure 3.2).  Although 9,127 out of 11,609 (78.6%) predicted genes from the 2009 
annotation set have an AED of less than 0.5, only 3,262 (28.10%) have AED scores less
than 0.3 and eight predicted genes have a AED score of zero (Table 3.1).  This implies
that there are significant disagreements between the predicted exons or splice sites and 
the newly assembled transcriptome and protein evidence (Table 3.1).
In a second estimate of improved quality, we used the old data (EST evidence
from JGI) with the newer annotation tools (the MAKER2-two-pass pipeline). In this case, 
the quality of the annotation set was improved with 402 (3.5%) out of 11,371 predicted 





















5,003 (44.00%) with AED scores less than 0.3, which indicated a much lower prediction 
accuracy (Figure 3.2). Therefore, although there were incremental improvements, the
older EST data was not fully effective at providing an accurate annotation even with 
newer bioinformatics tools (Table 3.1).
In contrast, the newer re-annotation set was generated with the assembled 
transcriptome and current protein evidence with the same MAKER2-two-pass pipeline. 
This returned a much-improved annotation build with 2,747 (24.6%) out of 11,171 
predicted genes having the perfect AED score of zero, 7,741 (69.30%) having the AED
score less than 0.3, and 9,392 (84.1%) having the AED score less than 0.5 (Figure 3.2;
Table 3.1). 
Sorting the predicted genes in categories
Using all 11,609 predicted genes from the prior annotation, 3,800 (32.73%) of 
were sorted into the Match category, meaning they share the same CDS coordinates and 
domain ID with the predicted genes from the newer (Figure 3.3). 3,854 (33.19%) of them
were sorted into the Similar category and 3,581 (30.84%) of them were sorted into the
Different category (Figure 3.3). 126 (1.1%) sorted into the Noexist category meaning 
they lacked any supporting evidence (Figure 3.3). Any remaining predicted genes from
2009 were not in any category because despite the existence of a transcript alignment
there was no gene model prediction in the newer annotation (Figure 3.3). This may be
because, for the C. parasitica genome, the protein evidence dataset in 
UniProtKB/SwissProt is derived from experimentally reviewed data of model organisms, 
so these may represent a set of genes that are specific to C. parasitica, or at least to its



















        
       
      
       
      
Quality comparison of the predicted gene models in the four categories of the
compared annotations
Figure 3.4 shows a comparison of the AED scores in the predicted gene models
from each category. The majority of predicted gene models in the Match, Similar and 
Different categories of the newer version have AED scores equaling to 0. In contrast, for 
the prior annotation there were two peaks for all three categories which contained the
majority of predicted gene models, one is between the 0.4 and 0.5, the other one is 1.0 
(Figure 3.4). 
Out of 3,800 genes in the Match category, there were 2,491 genes from the prior 
annotation with a conserved domain InterPro ID, but the newer annotation had 599 more
genes (3,090) with at least one conserved domain (Table 3.2). The possible reason for a
different protein product from the same CDS sequence is the reading frame shift or the
inaccuracy of translation in the JGI workflow with a given annotation file. No differences
were found in the Similar category because the strategy required that they must share the
same domain information (Table 3.2) only. There were 663 more predicted genes in the
newer annotation coding for at least one conserved domain in Different category than the
1,058 predicted genes of the prior annotation (Table 3.2).
Validation of the new predicted gene models by PCR
From the amplified transcript bands in agarose gel pictures of Appendix A chapter, 
for the Similar category, six out of seven chosen predicted genes were proven to support
the prediction of the newer version. For the Different category, 11 of 14 predicted genes
supported the newer version, while five of six predicted genes in the Noexist did not




      












the newer version (Table 3.3). In total, for the 27 predicted gene models of the prior 
annotation tested by PCR that were predicted to produce different transcript products in the
new annotation, 81.48% supported the newer predictions (Table 3.3).
Discussion
This study has provided a tool (PEPA) that can help to evaluate the prior 
annotation of a genome by analyzing and comparing the accuracy of each predicted gene, 
as well as the structural and functional features of each predicted gene, against the newer 
version, with no limitation of the format and the source of the prior annotation of a
genome. 
To test the efficacy of this tool, the prior annotation of C. parasitica was used as a
test. From the accuracy analysis and comparison, we have observed that the old 
annotation, although based on the best available tools and information at the time, 
contained many ambiguities and incorrect predictions. Even using the older evidence
with newer tools did not compensate for the lack of coverage provided by EST data only. 
However, when used in conjunction with RNA-Seq data prepared by the MAKER2-two-
pass pipeline used in Chapter II, the product was much more accurate gene models. 
The PEPA tool presented here also provides the utility of sorting and comparing 
the output of the annotations. This is especially important in order to be able to pursue
specific genes for functional studies. Given that 65.92 % of the prior predictions were
sorted in Match or Similar categories, this suggested that approximately 2/3 of the
predicted gene models have trustworthy annotation predictions in the older version. 

















    
with potential significant impact on further studies of either individual genes or large
scale analyses.
In addition to analyzing computational metrics such as AED scores to evaluate the
efficacy of the new annotation predictions, we also validated 27 specific genes
experimentally using PCR primers designed to differentiate between the old and new
predictions. The observation that 21 (81.48%) of them provided unambiguous support for 
the new annotation is further strong evidence of the improvement in accuracy. However, 
it also points to the important fact that with current available technology no annotation 
can be considered to complete or 100 % accurate. 
Before this study, there were multiple tools designed to compare two annotations, 
such as BEACON and gffcompare, or semi-automated genome annotation comparison 
[74-75]. BEACON was limited and only suitable for GenBank format annotation file
[74], while gffcompare was designed to compare two annotations in genome scale
statistically that does not provide the individual gene-level of resolution as produced by 
PEPA. The semi-automated genome annotation comparison scheme was designed to 
perform the functional comparison only between two annotations [75]. PEPA was 
designed to comprehensively compare two annotations of one genome in both accuracy 
and structure/function. A limitation of PEPA is the requirement to run multiple tools, 
such as MAKER2, as well as and R and python scripts.
Although tested here on the C. parasitica genome, PEPA is broadly applicable to 
other experimental systems where new data is available that was not present when an 
original genome annotation were prepared. This makes it possible to help the users to 
























design diagnostic PCR primers to validate their own specific areas of interest, and to 










     
        
        


















Table 3.1 The distribution of the predicted gene models’ AED scores in both genome
annotations.




2009-version 11,609 8 (0.06%) 3,262 (28.10%) 9,392 (80.90%)
2017-version 11,171 2,747 (24.60%) 7,741 (69.30%) 9,128 (81.71%)

























        
 
















Table 3.2 The distributions of the predicted gene models with conserved domain in 
each category from both annotation version.
Total Gene Match Similar Different
Predicted number With Without Match Without Mismatch Without
gene With Domain Domain Domain Domain Domain Domain
number domain
2009- 11,609 8,309 2,491 1,309 3,288 566 1,058 2,523
version









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   




Figure 3.1 The newly developed custom Python sorting schematic diagram
Predicted genes from the prior annotation (2009-vesion) were sorted into four categories, 
Match, Similar, Different, and Noexist based on their structural and functional










   




































0.0 0.2 0.4 0.6 0.8 1.0 
AED value 
Figure 3.2 Cumulative distribution of AED values in both annotation versions.
Shown on the x-axis is the AED score from 0 to 1, and y-axis is the cumulative
distribution of AED for each annotation version. (1) The red line presents the gene
models from 2009-version annotation completed by JGI tools with only ESTs as RNA
evidence. (2) The black line shows the gene models from 2017-version annotation 
generated with MAKER2-two-pass pipeline with RNA-Seq produced transcriptome as
RNA evidence. (3) The green line is a gene models generated as pipeline control using 


































Figure 3.3 The distribution of predicted gene models from the prior annotation (2009-
version) in the four categories.
(Orange pie) represents the portion of the total predicted gene models from the prior 
annotation that were sorted into the Match category. (Yellow pie) represents the portion 
of the total predicted gene models from the prior annotation that were sorted into the
Similar category. (Green pie) represents the portion of the total predicted gene models
from the prior annotation that were sorted into the Different category. (Maroon pie) 
represents the portion of the total predicted gene models from the prior annotation that
were sorted into the Noexist category. (Brown pie) represents the portion of the total
predicted gene models from the prior annotation that were sorted into the Others
category.
56






























0.0 0.2 0.4 0.6 0.8 1.0 
AED score (0−1) 
Figure 3.4 The AED score density curves of the predicted gene models from the
Match, Similar and Different categories of both annotation sets.
(1) Red line presents the AED scores density from DIFFERENT category genes of 2009-
version. (2) Red dash-line presents the AED scores density from SIMILAR category 
genes of 2009-version. (3) Red dot-line presents the AED scores density from MATCH
category genes of 2009-version. (4) Black line presents the AED scores density from
DIFFERENT category genes of 2017-version. (5) Black dash-line presents the AED
scores density from SIMILAR category genes of 2017-version. (6) Black dot-line









        
        
       
      
     
       
      
       
     
         
      
     
     
         
         
EXPLORE THE DOWNSTREAM TARGETS OF CPVIB-1 USING
TRANSCRIPTOME PROFILING OF THE CPVIB-1 MUTANT AND ITS WILD TYPE
STRAIN
Abstract
C. parasitica is the causal agent of chestnut blight, which devastated the American 
Chestnut population in the early 20th century. The discovery of hypoviruses that reduce the
severity of the chestnut blight infection offers the potential for biological control. However, 
the spread of the hypoviruses is hampered by a diverse nonself-recognition system, 
vegetative incompatibility (vic), among strains. VIB-1 in N. crassa has been reported as a
transcriptional regulator that is required for the expression of downstream effectors of N.
crassa’s nonself-recognition system, heterokaryon incompatibility (HI). CPVIB-1, as an
ortholog of the VIB-1, was identified as a transcription regulator playing an important role
in programmed cell death in response to allelic variation at the vic4 locus. In order to 
explore the downstream targets that interact with CPVIB-1 to mediate the various
phenotypic changes observed in the Δcpvib-1 mutant strain, including enhanced 
pigmentation and conidiation, less pathogenicity and reduced vic triggered program cell
death, RNA-Seq was used to profile the variation of expression patterns between Δcpvib-
1 mutant and wild-type strain. The high-quality RNA-Seq reads, were aligned against the




           
     
        
       






    





     
    
  
 
    
a list of read counts per transcript to indicate the significantly changed transcripts a
visualized expression pattern contrast between mutant and wild-type strain was used to 
examine biological processes altered by the absence of cpvib-1. In the absence of cpvib-1, 
there were 1,064 transcripts were altered significantly, with 245 (23%) up-regulated and 
819 (77%) down-regulated. CPVIB-1 was found to be a key universal transcription 
activator required for preventing oxidative stress, for glucose signaling pathway, for DNA, 
protein and lipids synthesis, and for the pathogenesis.
Introduction
The pathogen that causes the chestnut blight, C. parasitica, was first discovered in 
New York City in 1904 [18]. After the introduction from the imported chestnut nursery 
stock, C. parasitica spread very rapidly, resulting in a devastating epidemic in American 
chestnut population. [5]. While C. parasitica almost caused complete destruction of C.
dentata in USA, another chestnut species, Castanea sativa, suffered too in Europe.
However, 10 years after the disease was first reported in Europe, the transmissible
hypovirulence strains were discovered and identified to contain the transmissible RNA
virus attributing to the striking reduction in fungal virulence [16]. Later the transmissible
RNA virus was identified as a member of the hypovirus family and successfully applied 
as a biological way of controlling the spread of C. parasitica in Europe [76]. 
Unfortunately, the same strategy was not effective in North America [18]. The
reason for the failure was later proposed to be vegetative incompatibility, which induces
the sealing of the fused compartments that subsequently undergo programmed cell death 




   
     
   
 
   
  
   
  
  




    
  
  
     
 
      
 
incompatibility in C. parasitica is a nonself-recognition system, which is genetically 
controlled by at least six vegetative incompatibility (vic) loci [23; 63; 66; 77]. 
The mechanism of the genetic regulation of the vegetative incompatibility has
been studied extensively in one of the ascomycete species, N. crassa to reveal a broad 
regulatory process [32]. As one of the studied targets, VIB-1 was discovered to be
required for the programmed cell death and the hyphal compartmentation triggered by its
heterokaryon incompatibility (het-c) locus [32; 63; 66; 78]. As a transcriptional activator 
with a DNA binding domain NDT80/PhoG-like, VIB-1 was found to be a regulator of 
conidiation, non-repressible acid phosphatase, other heterokaryon incompatibility locus
(het-e, het-6, het-8) [63; 66; 78], downstream effectors associated with heterokaryon
incompatibility, and the carbon and nitrogen metabolism [32-33; 79]. 
As for the chestnut blight pathogen C. parasitica, CPVIB-1, a putative ortholog of 
VIB-1 was identified coding a protein of 688 amino acids in length, sharing 40% identity 
with VIB-1 from N. crassa and containing the same NDT80/PhoG-like DNA binding 
domain. It was reasonable to hypothesize that CPVIB-1 might represent a potential
candidate for modulation by hypoviruses by subverting the vegetative incompatibility. In 
order to test this hypothesis, a cpvib-1 deletion strain (Δcpvib-1) was established to test
its role in vegetative incompatibility system. The disruption of cpvib-1 in wild type
EP155 strain exhibited reduced virulence, reduced aerial hyphal growth and profuse
conidiation. Furthermore, CPVIB-1 was demonstrated to be required for programmed cell
death and barrage formation between two incompatible strains with different alleles in 
vic4 locus in the vegetative incompatibility assay. Thus, it is clear that CPVIB-1 plays a











   










parasitica as well as the virulence, hyphal growth, pigmentation, and the conidiation 
process. 
With the knowledge of VIB-1 mediating multiple downstream targets associated 
with heterokaryon incompatibility and the carbon and nitrogen metabolism in N. crassa,
we proposed the hypothesis that CPVIB-1 is a mediator of the vegetative incompatibility, 
the virulence, and the fungal vegetative growth processes requiring the interactions with 
the downstream effectors.
In this chapter, the first strategy we proposed to achieve the goal of testing the
above hypothesis was to carry out a comparative analysis of the large-scale transcriptome
profile between the Δcpvib-1 strain and its isogenic wild type EP155 strain. RNA-Seq is a
well-established high-throughput approach to obtain transcriptome profiling using the
NGS deep-sequencing technologies, which provides a far more precise measurement of 
levels of transcripts and their isoforms than other methods [80].
In this study, three biological replicates of the above two strains were cultured in 
the same conditions and their transcriptome library was prepared and sequenced in the
same lane using the RNA-Seq strategy described in chapters II and III. A widely applied 
transcriptome differential expression bioinformatics analysis pipeline was used to access
the quality of the RNA-Seq reads, and align them to the reference genome, assemble the
reads into transcripts, and count the read number mapped to each transcript [42; 81]. 
These data were used to infer functional and mechanistic pathway changes from the
Δcpvib-1 strain.
Consistent with the proposed role of VIB-1 made in N. crassa, CPVIB-1 was





   
   
 
 





   
    
  
   
   
  
  
parasitica. Moreover, compared to only the general metabolism pathways were 
highlighted to be significantly regulated using 2009-version annotation, there were 17 
metabolism pathways were significantly up-regulated including six carbon metabolisms
and 3 metabolism pathways down-regulated including RNA processing metabolism
pathways in the Δcpvib-1 strain.
Materials and Methods
Fungal transcriptome preparation and RNA-sequencing 
The wild type strain of EP155 was obtained from Dr. Donald L. Nuss (Center for 
Biosystems research, UMBI) and its isogenic cpvib-1 mutant strain was obtained from
Dr. Rong Mu (New Mexico State University). 
The preparation of transcriptome and RNA-sequencing for the wild type EP155 
strain of C. parasitica were demonstrated in Chapter II. At the same time and with the
exactly same procedure, the transcriptome of the cpvib-1 mutant strain was prepared and 
sequenced in the same Illumina lane. 
Differential expression analysis of the EP155 strain and its isogenic Dcpvib-1 strain
Similar to the one-step transcriptome assembly python scripts demonstrated in 
Chapter II, a python script pipeline was developed here to perform the first segment
(steps in blue frames) of the differential expression analysis workflow of the given two 
sets of RNA-Seq data, each from 3 biological replicates samples (Figure 4.1). The first
step of the pipeline is to inspect the reads quality of each RNA-Seq raw sequencing file
with FastQC [82]. Based on the quality output from the last step, Trimmomatic was the




   





   
   
 
 






remaining paired-end reads were aligned to the C. parasitica reference genome from JGI, 
the same one used in the Chapter II and III, with Bowtie2 and TopHat [42; 44; 52; 84-85;
]. Subsequently, all mapped reads were sorted with Samtools and counted per transcript
with HTseq-count using both the 2009-version annotation and 2017-version annotation as
references. [86-87]. 
The python scripts file differential_expression.pipeline.py can be downloaded 
from the GitHub website (https://github.com/didiren/RNA-seq-differential_expression)
and run for one-step transcriptome assembly in any system with Bowtie2, TopHat, 
Samtools, HTseq-count and Python available. The details of how to run the pipeline are
in the README.md file at the same web address.
Differential expression analysis with DESeq2
The reads count text files output from HTseq-count were fed into DESeq2, an R 
package providing the means to test differential expressed genes from the Dcpvib-1 strain
compared to the EP155 strain by using the negative binomial generalized linear models
[88]. In this study, it is the first step of the second segment (steps in orange frames) in the
differential expression analysis workflow (Figure 4.1), included in a R script to 
summarize the reads count from all six samples to a condition dependent count matrices, 
analyze the count matrices for differentially expressed genes, visualize the results and 
cluster samples and genes using transformed counts. This R script is available in the








   
   
    




   
  









KEGG pathways enrichment analysis with GAGE and Pathview R packages
As the second step of the second segment (steps in orange frames; Figure 4.1), a
few tools were utilized together to discover the significantly regulated metabolism
pathways in the Dcpvib-1 strain compared to the EP155 strain. At first, the BLASTp 
program from NCBI was used to match all genes from C. parasitica to their ortholog
genes in N. crassa. Then the ortholog KEGG ID of N. crassa was extracted and replaced 
the original C. parasitica gene ID in the output reads count text files generated from
HTseq-count. Second, to enrich sets of related genes sharing the same metabolic
pathways from the gene expression data, the Generally Applicable Gene-set Enrichment
(GAGE) was applied to this study [89]. All reads count text files with the N. crassa
KEGG ID now were fed to the GAGE package to highlight the significant regulated 
metabolic pathways in the Dcpvib-1 strain compared to the wild type strain based on the
integrated p-value from all related genes in the same pathways. The R/Bioconductor 
package, Pathview, was used to visualize the individual metabolic pathways from KEGG
by automatically downloading the pathways graph data, parsing the data file, mapping the
output data from GAGE to the data file and integrating the results to a new Graphviz
graph along with the native KEGG view graph [90-91]. A python script and R script to 
run ID conversion and GAGE as well as Pathview are listed in the GitHub website
(https://github.com/didiren/RNA-seq-differential_expression) mentioned above.
GO enrichment analysis with REVIGO
As the last segment (steps in green) of the differential expression analysis
workflow (Figure 4.1), a web server, Reduce and visualize gene ontology (REVIGO) was











    
   
 
  






subset of the terms using a simple clustering algorithm that relies on semantic similarity 
measures [92]. Essentially, the significantly differential expressed genes from DESeq2 
that were statistically interpreted with the p-values lower than 0.05 and the log2 fold 
change larger than +2/-2 were subsequently linked to the GO ID of each gene by a small
python script. Next, REVIGO was used to cluster and visualize the non-redundant GO
term set to facilitate the interpretation of the output of differential expression of large set
of genes from DESeq2 [92].
Results
Quality assessment of RNA-Seq reads and alignments in Dcpvib-1 strain
The transcriptome of three Dcpvib-1 strain biological replicates were sequenced 
with the isogenic wild type EP155 strain in the same lane using the Illumina paired end 
sequencing technology. There were 24 to 47 Million reads for these three libraries with 
the average mean quality scores of 35.57 to 35.75 and >=Q30 scores of 93.82% to 
94.74% (Table 4.1). With the quality examination by FastQC, there were no adapters or 
poor quality reads with a mean quality score lower than 25 detected in all three Dcpvib-1
strain libraries, and the same for EP155 samples. In the light of the discovery that
trimming process of RNA-Seq reads could alter the expression pattern estimation of 
samples, the Trimmomatic step was skipped in this study to avoid the unnecessary bias
leading to the inconsistent results [93]. After the alignment with Bowtie2 and TopHat, 
there were 95.45% to 97.02% reads from the three samples of the Dcpvib-1 strain mapped 
to the reference genome along with approximately 93% reads being concordant from




   
 










libraries for both the Dcpvib-1 strain and the EP155 strain was consistent among the
biological replicates. 
Differentially expressed genes in the Dcpvib-1 strain
The matrix with six columns and 11,171 rows (after mapping to 2017-version 
annotation reference) were normalized by modeling with negative binomial distribution 
with both the mean, dispersion values and the individual normalization size factors of 
each gene. Then, both the fold change and its dispersion (estimated standard error) 
between the treatment (Dcpvib-1) and control (EP155) were included in the reduced 
process to report the significantly differentially expressed genes. In this case, the log2 
fold change plot was a useful overview of the differential expression analysis of the
Dcpvib-1 strain compared to EP155 strain results from DESeq2 (Figure 4.2). This plot
demonstrated that some genes with small normalized count (in the left part of Figure 4.2) 
were also called significant with a small p-value, leading to the requirement of the
DESeq2’s shrinkage estimation strategy by considering the dispersion factors within the
group variability. The red trend line showed the dispersions’ dependence on the mean 
that was set to shrink each gene’s estimates (black dots) towards to the trend to obtain the
final estimates (blue dots) as well as the dispersion outliers (blue circles) were cut from
the total gene sets because of the high gene-wise dispersion estimates (Figure 4.3). The
dispersion value was estimated to be 0.01 in this study represented the gene’s expression 
tends to differ 10% between samples of the same group [88].
It was important to perform the sample difference and clustering analysis between 

















expectation.  In order to fulfill the goal, at first, the regularized-logarithm transformation 
(rlog) strategy of DESeq2 was used to get rid of the bias of a few low reads count
contributing to the major absolute differences between samples. In this study, there were
two ways to present the differences of six samples after the rlog transformation. The first
mean is to calculate the Euclidean distance between each two samples in counting of all
genes in the genome and visualize in the heatmap (Figure 4.4) and the second one is to 
cluster the top significantly down-regulated genes in the two strains based on their 
expression level and visualize them in a heatmap (Figure 4.5). The results from both 
means were consistent in clustering the three biological replicates of each strain together 
and different from the three biological replicates of the other strain.
To further validate the quality improvement of the 2017-version annotation, the
same differential analysis workflow was performed but using the 2009-version annotation 
as the reference for the HTseq-count step. There were 819 genes significantly down-
regulated with a log2 fold change less than -2 and 245 genes significantly upregulated 
with a log2 fold change larger than +2 while using the 2017-version annotation as
reference (Table 4.3). On the contrary, 958 and 251 genes were found significantly down-
regulated and upregulated in the same level while using the 2017-version annotation as
reference (Table 4.3).
Significantly regulated KEGG metabolism pathways in Dcpvib-1 strain
As one of the GSA tools, GAGE was designed to reveal the relevant regulatory
mechanisms from the transcriptome scale based differential expression analyses. In this
study, the transcriptomes of Dcpvib-1 strain was the treated group and the EP155 strain 







   
 




   
 
   
     
  
 
   
 
mentioned above. After the ID conversion using BLASTp and IDcoversion.py, 7,079 out
of 11,171 genes returned the N. crassa KEGG ID compatible with the GAGE and 
Pathview tools. The normalized expression level of each gene with a recognizable KEGG
ID matrix was fed to the GAGE with the N. crassa metabolism pathways KEGG dataset
as reference. 
In the end, there were 91 metabolic pathways summarized to be different with 
statistical data in the Dcpvib-1 strain compared to the EP155 stain. Twenty-nine of them
were down-regulated and 62 up-regulated, respectively. Furthermore, GAGE provides a
z-test to compare the net effect of differential expressed gene while using the as.group 
option rather than the paired_sample option leading to a relatively larger but more
reliable p value [89]. There were two metabolic pathways highlighted as significantly 
down-regulated (p.value <0.1, highlighted in green) and 19 significantly up-regulated 
(p.value <0.1, highlighted in red) in the Dcpvib-1 strain from the GAGE analysis (Table
4.4). 
In the down-regulated pathway group, the top four were the RNA transport, 
Ribosome, Aminoacyl-tRNA biosynthesis, and the mRNA surveillance pathways are all
down-regulated with the relatively lower statistics means (stat.mean: mean of the gene-
set transcription level changes) from -0.27 to -0.77 in the Dcpvib-1 strain compared to the
EP155 strain (Table 4.4).  The next four were the Proteasome, Arginine and proline
metabolism, Ubiquitin mediated proteolysis and the Alanine, aspartate and glutamate
metabolism pathways with the statistics means from -0.18 to -0.2 in the Dcpvib-1 strain 






    
  
   




   
 
   
  






   
In the up-regulated pathway group, four of the top five were the Biosynthesis of 
antibiotics, Biosynthesis of secondary metabolites, Carbon metabolism, and the
Biosynthesis of amino acids pathways (Table 4.4). All of the listed pathways are the 
broad metabolism pathways composed of many individual pathways and highlighted here
because the clustering of those individual pathways. Except for the above three, the most
up-regulated pathway in the Dcpvib-1 strain is the Glycolysis / Gluconeogenesis pathway
(Table 4.4). Furthermore, in all the 15 individual significantly up-regulated pathways, 
eight of them were the individual carbon metabolic pathways (Table 4.4). 
In contrast, while using the 2009-verison annotation as reference in HT-seq-count
and the same following procedures described above, in the ID conversion step, 7,007 out
of 11,609 genes returned the N. crassa KEGG ID compatible with the GAGE. There
were three metabolism pathways highlighted as significantly down-regulated (p.value
<0.1, highlighted in green) and five significantly up-regulated (p.value <0.1, highlighted 
in red) in the Dcpvib-1 strain (Table 4.5). In the five significantly up-regulated pathways
highlighted in red, there was only one individual carbon metabolism pathway (Table 4.5).
The Pathview package was used to visualize the pathways of interest in this study. 
First, in the up-regulated pathways group in the Dcpvib-1 strain, the ncr00010 Glycolysis
/ Gluconeogenesis pathway was presented with all critical enzymes in one string 
regulated consistently (Figure 4.6).  The ncr00500 Starch and sucrose metabolism, the
ncr00052 Galactose metabolism, and the ncr00680 Methane metabolism that are all
linked to the glycolysis in the bigger view were presented with most critical enzymes
consistently flowing to the D-glucose (Figure 4.7, Figure 4.8, Figure 4.9). One special






    














4.10). Besides, the ncr03013 RNA Transport pathway and ncr04120 Ubiquitin mediated 
proteolysis pathway was presented as the examples for the down-regulated pathways
group in the Dcpvib-1 strain (Figure 4.11, Figure 4.12).
Significantly expressed genes’ GO enrichment in Dcpvib-1 strain
REVIGO was used to cluster the GO terms based on the functional similarity by 
feeding with a matrix of the GO term and its associated log2 fold change.  The table
showed the most frequent GO terms in the significantly regulated genes in the Dcpvib-1
strain (Table 4.6). The results showed a small number of top-ranking GO terms with a
dispensability value as 0 were the GO:0003700 transcription factor activity, GO:0003884 
D-amino-acid oxidase activity, GO:0005375 copper ion transmembrane transporter 
activity and the GO:0045735 nutrient reservoir activity and all having the log2 fold 
change value less than -2, except the GO:0005096 GTPase activator activity with a log2 
fold change value as 3.23 (Table 4.6). Moreover, there were some more GO terms related 
to carbon and lipid metabolism and DNA polymerase activities that were listed in the
table as well drew the attention because of the phenotype shift in the Dcpvib-1 strain and 
former studies of VIB-1 in N. crassa (Table 4.6).
In addition to a table format, REVIGO provides three additional visualization 
strategies. First, the scatterplot was draw based on the semantic similarities of the GO
terms (x axis) and the log2 fold change values (y axis). The scatterplot here showed the
up-regulated clusters (Red color bubbles) were the Oligopeptide transport, Carbohydrate
metabolism, Proteolysis, Carboxylic acid metabolism, etc. (Figure 4.13). Meanwhile, the




















metabolism, lipid catabolism, RNA processing, iron transmembrane transport, and others
(Figure 4.13).
The second presentation method is the graph-based clusters interaction view, 
which using a node to represent a cluster from the scatterplot and use the edges to 
represent at least 3% of the strongest GO term pairwise similarities. The interactive graph 
showed the level of the transcription regulating was related to RNA process and the
nucleoside metabolism, which related to the carbon, lipid and protein metabolism (Figure
4.14). On the other side, another interactive net was listed here of different molecule
transport processes, which were highlighted and linked with each other (Figure 4.15).
The last presentation method is the treemap showing the two-level hierarchy of 
GO terms by joining the clusters from the scatterplot and interactive graph to several
high-level groups. In the treemap graph, each rectangle represents a single cluster, which 
were joined into the superclusters in different colors. It was obvious that the D-amino 
acid metabolism was the most major supercluster regulated in the Dcpvib-1 strain (Figure
4.20). The response to stress, pathogenesis, molecular transport, and carbon metabolism
were highlighted as the relatively smaller superclusters, which were consistent with the
phenotype observed in the absence of cpvib-1 (Figure 4.16).
Discussion
RNA-Seq is now widely used to reveal the transcriptome profile in organisms and 
can be essential for interpreting the functional elements of the genome and revealing the
molecular constituents of the metabolic pathways. The depth of data assisted the re-













   
 
  
     
  
 
Here, it was utilized to provide insights into the regulation mechanisms of the
transcriptional activator CPVIB-1 in the plant pathogen C. parasitica.
As mentioned in Chapter II concerning the quality of the RNA-Seq reads and 
their alignment percentages to the genome, both the transcriptome of the Dcpvib-1 and 
EP155 strains shared similar high-quality results as described in Results of this Chapter.  
Furthermore, with the advanced rlog strategy to remove the bias of the low count reads
from the biological replicates of two strains, the sample transcriptome profiles’ similarity 
was displayed in the Euclidean distance heatmap and expression level heatmap, 
indicating their consistency within the same strain and differences among the two strains. 
The above results provided evidence to confirm the accuracy of the RNA-Seq platform
and credibility of the library preparation of the samples.
CPVIB-1 was found to be a universal transcriptional activator itself by the
differential expression analysis using DESeq2 after the normalization and statistics
analysis. There were 1,064 genes (approximately 10% of the genome) found significantly 
regulated with a p-value < 0.05 and log2 fold change’s absolute value > 2 in the Dcpvib-1
strain (Table 4.3). Moreover, the GO term clusters summarized from the significantly 
regulated genes in the Dcpvib-1 strain (Table 4.6) showed great diversity.  One of the
highlighted GO term is GO:0003700 transcription factor activity with a mean log2 fold 
change value as -2.3627 indicating the transcript level of various transcription factors
were down-regulated in the absence of the cpvib-1 gene in C. parasitica (Table 4.6). This
result was found to be consistent with the phenotype shift of the Dcpvib-1 strain resulting 
in the slower hyphal growth rate, profuse conidiation and increased pigmentation caused 










   
 
 
   
  
 
   
 
  
CPVIB-1 was discovered to mediate the carbohydrate catabolite metabolism and 
other nutrient catabolite metabolism by affecting the hydrolytic-activity-related genes. 
Two sets of results were found to support this. First, there were five various but directly 
related specific KEGG carbon pathways found significantly up-regulated in the Dcpvib-1
strain (Table 4.4). The starch and sucrose metabolism taking both the polysaccharides
and sucrose as the sugar resource to produce the D-glucose (Figure 4.7). Also, as the
product of the methane metabolism as well as the fructose and mannose metabolism, the
fructose 6-P is convertible with D-glucose (Figure 4.9). Moreover, both the pentose
phosphate pathway and galactose metabolism are also leading to the product of D-
glucose, which is also reversible (Figure 4.8). Almost all enzymes that are comprising the
glycolysis/gluconeogenesis pathway were regulated in the Dcpvib-1 strain and they were
consistently regulated in the same metabolic flow direction to consume the glucose to the
citrate cycle for ATP synthesis (Figure 4.6). 
During the conversion of KEGG ID’s from C. parasitica to N. crassa, we found 
that only 7096 genes were mapped to the KEGG pathways, presumably due to N. crassa 
possessing different pathways. Given N. crassa is not a pathogen, pathways of specific
interest to the understanding of such behavior could be missed and thus they would not
be highlighted. Additionally, therefore, we use REVIGO term enrichment analysis to 
provide additional global information. In the Dcpvib-1 strain transcriptome, the results
from the clustered GO terms in scatterplot indicated the up-regulation of carbohydrate, 
carboxylic acid and amine catabolism metabolism as well as the down-regulation of lipid 
and D-amino acid metabolism with the log2 fold change values larger than +4 (Figure













   
   





Dcpvib-1 strain transcriptome, the major super-group that were significantly regulated 
were the nutrient metabolism, molecular transport (Figure 4.16). In N. crassa, VIB-1 was
found to repress the glucose signaling and encourage the carbon catabolite repression 
process, thus enabling a proper cellular response for plant biomass deconstruction [34]. 
Therefore, it was not surprising that the Dcpvib-1 strain resulted in encouraging the
utilization of carbon catabolite and glucose signaling process without the presence of the
CPVIB-1. 
CPVIB-1 was also found to be a mediator to the pathogenesis of C. parasitica.
Although the KEGG pathway analysis did not highlight pathways in the Dcpvib-1 strain 
related to the pathogenesis, the GO term enrichment analysis highlighted a cluster of 
genes related to the pathogenesis with a mean log2 fold change value as -6 (Figure 4.13). 
Additionally, the super-group treemap graph of the clustered GO terms in the Dcpvib-1
strain transcriptome highlighted the pathogenesis super-group (in pink color) as one of 
the major significantly regulated super-groups (Figure 4.16). In conclusion, the down-
regulation of pathogenesis related genes in the Dcpvib-1 strain was consistent with the
virulence attenuation phenotype we found in the virulence assay of the Dcpvib-1 strain.
CPVIB-1 was discovered to be essential for proper RNA processing and 
biosynthesis. Both the KEGG pathway analysis and GO term enrichment analysis were
consistent in presenting the significant down-regulation these pathways in the Dcpvib-1
strain. Similar results were reported in N. crassa that VIB-1 mutant strain displayed 
significantly reduced hyphal growth rate and reduced cellulose consumption level. 
The absence of CPVIB-1 triggered the higher transcription level of genes

























the transcriptome of the Dcpvib-1 strain, the oxidative phosphorylation pathway,
oxidation reduction process and oxygen binding GO term cluster were both found 
significantly up-regulated. Without CPVIB-1 the balance of producing and eliminating 
reactive oxygen species (ROS) was disturbed leading to the oxidative stress which can 
lead to the severe damage of DNA, protein and lipids [94]. In response to the stress in the
absence of CPVIB-1, the genes related to response to the oxidative stress were
transcribed in higher level. 
With all the above results, it is now clear that the absence of the key universal
transcription activator CPVIB-1 caused the imbalance of stress response systems, altered 
DNA, protein and lipids synthesis, disturbed various transcription factor activities and 
also RNA processing. The attenuated pathogenesis feature might be caused by the
glucose signaling pathway shift in the Dcpvib-1 strain preventing the fungus from
utilizing the plant cell wall components, like cellulose. These results indicate that
CPVIB-1 is a much more global regulator than was first suspected, and is critical for the






      
 
    
    
    
    
 

















Table 4.1 RNA-Seq read quality of three biological replicates from the C. parasitica
Dcpvib-1strain.













*% of >= Q30 Bases means the percentage of all bases in a read containing no more than 














      
      





















Table 4.2 The quality of read alignments from Dcpvib-1 strain.
Sample Reads Reads number aConcordant bDiscordant
Yield mapped to pair alignment alignments rate
(Million) genome rate
Dcpvib-1s1 47.00 44.86 M (95.45%) 92.5% 0.4%
Dcpvib-1s2 24.27 23.53 M (96.95%) 93.5% 0.6%
Dcpvib-1s3 33.99 32.98 M (97.02%) 93.4% 0.7%
a Concordant pair alignment rate, referring to the percentage of reads from both paired-
end sequencing file matched to the same locus in the genome. 
b Discordant alignment rate, referring to the percentage of reads from both paired-end 




   
 
   
   
   











Table 4.3 The number of significantly regulated genes in the Dcpvib-1 strain 
compared to EP155 strain.










These are significantly regulated gene number with a p adjusted value less than 0.05 and 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.1 The differential expression analysis workflow. 
Blue frames were included in the python on-step pipeline. Orange frames were included 














Figure 4.2 Log2 fold change plot of the Dcpvib-1 strain over the mean of normalized 
counts. 
The plot represents each gene with a dot. The x axis is the average expression over all
samples, the y axis is the log2 fold change between treatment and control. Genes with an 
adjusted p value below a threshold (here 0.1, the default) are shown in red. The red 
labeled triangles at the bottom represents the genes with a log2 fold change less than -10 
and an adjusted p value below 0.1. This plot demonstrates that only genes with a large










Figure 4.3 Dispersion plot of the Dcpvib-1 strain over the mean of normalized counts.
One black dot represents a gene’s original dispersion and the mean of normalized counts. 
One blue dot represents the gene shrunken version of the dispersion and the mean of 
normalized counts. The red line is the trend of the mean of the dispersions of all genes.  






























































Figure 4.4 Heatmap of Euclidean sample distances of six samples in two strains after 
rlog transformation. 
Three biological replicates for EP155 strain were labeled with untreated_1, untreated_2, 
untreated_3.  
Three biological replicates for Dcpvib-1strain were labeled with VIB1treated_1, 
















































































Figure 4.5 Heatmap of the top 25 significantly down-regulated genes clustering in six 
samples. 
Three biological replicates for EP155 strain were labeled with untreated_1, untreated_2, 
untreated_3.  
Three biological replicates for Dcpvib-1strain were labeled with VIB1treated_1, 










   
    
Figure 4.6 KEGG view of ncr00010 Glycolysis / Gluconeogenesis pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. 
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. 
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain. 












   




Figure 4.7 KEGG view of ncr00500 Starch and sucrose metabolism pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. 
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. 
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain. 





     
   
 
   
  
    
    
Figure 4.8 KEGG view of ncr00052 Galactose metabolism pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. 
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. 
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain. 





    
   
 
   
  
    
     
Figure 4.9 KEGG view of ncr00680 Methane metabolism pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. 
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. 
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain. 





    
   
 
   
  
    









Figure 4.10 KEGG view of ncr00190 Oxidative metabolism pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. 
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. 
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain. 






    
   
   
    
    
 
 
Figure 4.11 KEGG view of ncr03013 RNA Transport metabolism pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. Each gray labeled frame stands for an enzyme with no fold change in the





    
   
   
   






Figure 4.12 KEGG view of ncr04120 Ubiquitin mediated proteolysis pathway.
Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.  Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.  Each gray labeled frame stands for an enzyme with no fold change in 
















Figure 4.13 The “Scatterplot & Table” view of REVIGO showing the GO clusters of 
the significantly regulated genes in the Dcpvib-1 strain.
The y axis represents the log2 fold change value of each GO term. The x axis represents
the semantic scale of the GO terms. The bubble color indicates the log2 fold change value
from the positive (red, up-regulated) to negative (blue, green, and yellow down-












Figure 4.14 The “Interactive graph” view of REVIGO presenting the carbon, nitrogen 
metabolism clusters and their interactive RNA processing clusters in nodes
and their interactive relationship by edges from the significantly regulated 
genes in the Dcpvib-1 strain.
The bubble size refers to the number of genes in the biological processes. The log2 fold 















Figure 4.15 The “Interactive graph” view of REVIGO presenting the clusters of 
different transport process in nodes and their interactive relationship by 
edges from the significantly regulated genes in the Dcpvib-1 strain.
The bubble size refers to the number of genes in the biological processes. The log2 fold 
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Figure 4.16 The “Treemap graph” view of REVIGO representing the supercluster 
groups in different colors. 
One rectangle is representing a cluster from the scatterplot and interactive graph. Each 
color represents a supercluster group. The size of the rectangle is adjusted based on the













   
    
 
  
IDENTIFYING THE DIRECT TAGETS OF CPVIB-1 USING CHROMATIN
IMMUNOPERCIPITATION SEQUENCING
Abstract
Genetic regulation of vegetative incompatibility (vic) has been hypothesized to be
a means of limiting the spread of hypoviruses. Compatible strains will form a stable
heterokaryon, while incompatible strains will seal fused compartments that subsequently 
undergo programmed cell death. The transcriptional factor CPVIB-1 was found essential
for the processes leading to vegetative incompatibility in C. parasitica, a model system
for hypovirus-host interactions. In order to explore the direct targets of CPVIB-1, a
detectable FLAG-tagged CPVIB-1 construct was transformed into the Dcpvib-1 strain. A
ChIP-Seq strategy was applied to reveal the precise recognition sequence and target
genes potentially regulated by the CPVIB-1 protein. We found the GAGA-repeat motif 
was recognized and bound specifically by the CPVIB-1 protein. We found 264 genes that
CPVIB-1 targeted with function in remarkably diverse biological processes, including 
cell fusion, transcription, translation, autophagy, telomere maintenance, response to 
oxidative stress, lipid and protein biosynthesis, and carbon metabolism.  From a former 
study, the TOR signaling pathway was demonstrated to be inactivated by both rapamycin 
and nutrient starvation, thus mimicking the vic response. Combined, our data revealed by 



















indicate the connection of rapamycin, nutrient starvation, CPVIB-1 and the TOR 
signaling pathway in C. parasitica. This represents the first report that CPVIB-1 is
induced by rapamycin treatment and carbon starvation treatment, that CPVIB-1 is
essential for rapamycin to trigger autophagy, that CPVIB-1 is essential for both 
rapamycin and nutrient starvation to inhibit the hyphal growth, and that CPVIB-1 targets
the TOR2 subunit directly. In conclusion, CPVIB-1 is a GAGA factor (GAF) interacting 
with a large collection of factors and genes that function in many different aspects of 
gene activity, chromosome structure and cell development and can be stimulated by 
rapamycin and nutrient starvation to inhibit the TOR signaling pathway.
Introduction
In the chestnut blight pathogen fungus C. parasitica, the genetic regulation of 
vegetative incompatibility (vic), a form of nonself allorecognition, restricts transmission 
of the virulence-attenuating hypoviruses [20]. Paired strains of C. parasitica that have
allelic differences at vic loci display vegetative incompatibility responses, as recognized 
by programmed cell death leading to barrage formation [24; 95]. 
In N. crassa, VIB-1 has been highlighted as a transcriptional activator that is
required for the expression of downstream effectors responsible for programmed cell
death and the hyphal compartmentation triggered by the heterokaryon incompatibility 
(het-c) locus [32; 63; 66; 78]. In the plant pathogen C. parasitica, we have identified 
CPVIB-1, a putative ortholog of VIB-1, containing the same NDT80/PhoG-like DNA
binding domain. In exploring the role of a putative CPVIB-1 from the model system for 
mycovirus-host interactions and causative agent of chestnut blight, the deletion of cpvib-1










   
 
 
   
conidiation and defective vegetative incompatibility triggered by vic4, which indicated 
the role of CPVIB-1 is similar with the VIB-1 of N. crassa [32]. CPVIB-1 was also found 
to play a role in pathogenesis as well, suggesting a potential broad range of targets that
this protein may influence. In this system, we predict that CPVIB-1 is part of a signaling 
response, which is triggered by at least some of the allelic differences that define the
vegetative incompatibility system. Using a polymorphism-based comparative genomics
approach, six vic loci in the genome were recently identified [22-24], including vic-4, 
although it is not currently known whether CPVIB-1 is responsible for signaling 
generated by other allelic differences. 
The presence of a conserved DNA binding domain indicated CPVIB-1 may also 
act as a transcription factor and act to control the rate of transcription of genes by binding 
to specific DNA sequences in their promoter regions [96-97]. In order to further identify 
the downstream target genes of this potential CPVIB-1 activity, we began with 
comparison of large-scale transcriptome profiling of the Δcpvib-1 mutant strain and its
isogenic wild type EP155 strain using RNA-Seq [80]. With the absence of CPVIB-1, 
there were 1,064 transcripts altered significantly, with 245 (23%) up-regulated and 819 
(77%) down-regulated. This indicates CPVIB-1 is a key transcription regulator 
responsible for various biological processes, including response to oxidative stress, 
repressing the glucose signaling pathway, and control of the DNA, protein and lipid 
synthesis, all of which could contribute to affect the observed reduced virulence of the
knock-out strain.
A more direct strategy to reveal the direct targets of CPVIB-1, chromatin 



















   
   
binding locations of the CPVIB-1. In 2007, Robertson G et al. first developed the ChIP-
Seq method and used it to identify the DNA sequences bound by transcription factors
STAT1 in interferon g (IFNg)-stimulated and unstimulated in human cells [99]. Since
then, the ChIP-Seq method has become the most popular strategy due to its ability to 
identify the target DNA sequences of the protein of interest rapidly, with high efficiency 
and relatively low cost [100]. Here in this study, ChIP-Seq method was used to discover 
the DNA binding location of the transcription factor CPVIB-1 and identify the genes it 
targets in both rapamycin treated and untreated samples. 
Rapamycin is known to be a compound with remarkable anti-fungal and 
immunosuppressive properties by acting with peptidyl-prolyl isomerase FPR1 to 
influence the Target Of Rapamycin (TOR) complex in yeast [101-102]. The TOR 
signaling pathway was subsequently discovered to be a conserved central controller of 
cell growth from yeast to humans in response to nutrient availability, stress, and growth 
factors [103-104]. Later in 2003, Dementhon et al. successfully linked the programmed 
cell death process trigged by vegetative incompatibility to the autophagy induced TOR 
signaling pathway in one of the model fungal species, P. anserina [105]. In the light of 
rapamycin treatment mimicking the vegetative incompatibility response, we used 
rapamycin in our ChIP-Seq experiment to identify the targets of CPVIB-1 that pertained 
specifically to the vegetative incompatibility pathway. Unexpectedly, this has revealed a
relationship between CPVIB-1 and the TOR signaling pathway as well.
ChIP-Seq requires the ability to detect and recover the DNA portion of interest. 
Therefore, we used a FLAG-tagged CPVIB1 protein expressed in the Δcpvib-1 mutant













tag is a short peptide sequence (DYKDDDDK) that is easily and specifically recognized 
by the commercially available anti-FLAG antibody. This system has been widely used in 
western blot, immunohistochemistry, and immunoprecipitation with high specificity and 
protein expression, modification, purification without affecting the biological function of 
the tagged protein due to the small size [106-108]. With this tool validated we could then 
proceed with crosslinking of FLAG-CPVIB-1 protein, recovering the fixed protein-DNA 
complexes using the anti-FLAG antibody and then recovering the bound DNA for library 
preparation and analysis by high-throughput sequencing [100; 109]. 
With the 16 to 26 million reads generated from the FLAG-tagged CPVIB-1 
samples and its rapamycin treatment samples this strategy found 275 and 357 peaks in the
rapamycin untreated and treated samples, respectively. 264 (untreated) and 292 (treated) 
of these were found to be in the region of annotated genes using our newly prepared 
genome annotation (see Chapter III). We have identified GAGA-repeats that were found 
to be the specific binding sites of CPVIB-1 in both treated and untreated samples. 
Association with this GAGA motif places CPVIB-1 functionally in the GAGA factors
(GAFs) family. This family of proteins has an extraordinarily diverse set of functions
including the activation and repression of gene expression, nucleosome organization and 
remodeling, higher order chromosome architecture and mitosis [96; 110-112]. In 
accordance with these broad roles, CPVIB-1 was found to target genes with functions in 
cell fusion, transcription, translation, autophagy, telomere maintenance, response to 
oxidative stress, and lipid and protein biosynthesis. Furthermore, we found that the









   
 









subunit and several transcriptional factors playing roles in phosphorylation, protein 
repair, and cell redox homeostasis. 
From work in yeast, we know that both rapamycin and nutrient limitation inhibit
the TOR signaling pathway, which controls the various cellular processes [103; 113]. 
With our results, we can now associate CPVIB-1 to the TOR signaling pathway and 
provide evidence for the connection between the TOR inhibitors, nutrient limitation and 
response to rapamycin with the CPVIB-1 protein. 
Materials and Methods
Fungal spheroplast preparation
The following fungal spheroplast preparation protocol was adopted from the
paper of Churchill [114]. The Dcpvib-1 mutant strain was previously prepared by Dr. 
Rong Mu and cultured in 50 ml potato dextrose broth (PDB; Difco, Sparks, MD) at room
temperature on the bench for four days. After the homogenization of the fungal culture
and addition of another 50 ml fresh PDB broth, the hyphal cells were expected to achieve
log phase growth rate. The suspended mycelium particles were collected by filtering 
through sterile Miracloth® (Calbiochem) and then washed with 0.6 M MgSO4 
thoroughly. Harvested mycelium were then tapped dry with paper towels and transferred 
to a flask containing 50 ml Digestion Buffer (Table 5.1) to break down the fungal cell
wall by incubating overnight on a platform shaker at 100 rpm at room temperature. 
The next day, 10 ml of the spheroplast suspension was aliquoted into 50 ml
polypropylene tubes and 12.5 ml cold sterile Tapping Buffer (Table 5.1) was gently 
overlaid onto the spheroplast suspension to form a clear interface between two layers. 













      
  
   
  








35 minutes. The spheroplast tube was placed on ice gently and the cloudy interface
containing spheroplast was collected to a new 50 ml polypropylene tube. In the same
tube, 2 volumes of 1 M sorbitol solution was slowly added to the harvested spheroplast
suspension with gentle mixing. The diluted spheroplast were pellet down by 
centrifugation in Beckman JS13 rotor at 7,000 rpm at 4 ℃ for 6 minutes.  
Supernatant was removed and the spheroplast pellet was suspended in 5 ml of 
STC (Table 5.1) and centrifuged in Beckman JS13 rotor at 7,000 rpm at 4 ℃ for 10 
minutes. Supernatant was removed and the pellet was suspended with 100 – 200 µl of the
solution with 4 parts STC (Table 5.1), 1 part PTC (Table 5.1), and 0.05 parts DMSO. The
re-suspended spheroplast of the Dcpvib-1 mutant strain were stored at -80 ℃.
Epitope FLAG-tagging of cpvib-1 gene
The cpvib-1 gene is 2546 nucleotides in length and encoding a protein product
with 688 amino acids in length and 72 kilodaltons (KDa) in weight. The FLAG epitope
tag (DYKDDDDK) was tagged to the N- terminus of the cpvib-1 gene using the protocol
described by McClean [115]. Briefly, the addition of FLAG-tag was achieved by PCR 
using the primer set CPVIB1-nFLAG (sense sequence: 5’-
AGCGGCCGCATGGATTACAAGGATGACGACGATAAGATGGCAGAGTTGAAG 
GAGCCGGCG -3’ and anti-sense sequence: 5’-
AAAGCTTTTACGATGTGTTCCACGAGTAGTGGCC -3’). Purified PCR products
from a 1% agarose gel were cloned into the StrataClone PSC-A-amp/kan PCR cloning 
vector (Agilent, USA) with instruction manual for sequencing. Confirmed FLAG-tagged 
cpvib-1 sequences were removed and purified from pSC-A cloning vector using the




   
 
     
      
        
        
   
       
     
         
      
      
 
      
    
     
    
      
        
         
        
    
FLAG-tagged cpvib-1 DNA products were subsequently cloned into a C. parasitica
expression vector, pCPXNBn1, containing a benomyl selection cassette. 
Transformation of the FLAG-tagged cpvib-1 gene into the Dcpvib-1 strain
The above construction of the expression vector and the FLAG-tagged cpvib-1 gene
was transformed into fungal spheroplast prepared in the first step of Methods and Mateirals
in this Chapter [114]. At first, 200 µl of the Dcpvib-1 strain fungal spheroplast were quickly 
thawed at 37 ℃ then placed on ice. Subsequently, 5-10 µg of FLAG-tagged CPVIB-1 
expression construction DNA was added to a pre-cooled 15 ml FalconTM tube and gently 
mixed with 100 µl thawed spheroplast. A control was set up using autoclaved distilled 
water as DNA input with the same amount of spheroplast. The mixture was incubated on 
ice for 30 minutes and gently added 1ml PTC (Table 5.1) with a following incubation at
room temperature for 25 minutes. In the end, 1ml of STC (Table 5.1) was then added and 
mixed gently and aliquoted to petri dishes in small droplets.
Subsequently, 12.5 ml of 45-48 ℃ Regeneration Medium (Table 5.1) was pipetted 
onto the droplets and swirled to mix with the transformed spheroplast thoroughly and 
allowed to solidify at room temperature. After 16-18 hours of incubation at room
temperature, another 12.5 ml of 45-48 ℃ Regeneration Medium (Table 5.1) containing 
desired selective agent Benomyl (Aldrich chemistry, USA) with the final concentration as
500ng/µl was added to overlay the first Regeneration Medium layer. The plates were then 
kept on the bench for 5-9 days at room temperature to germinate hyphae on the top layer. 
Individual transformants that survived Benomyl selection were picked out to inoculate the




       
       









      
       
        
    
        
    
           
        
       
        
 
process for 7-9 days. In the end, the diluted spores were spread on the Benomyl selection 
PDA (final concentration as 400 ng/µl) plates for the second selection process, therefore
the positive transformants were obtained from the thriving colonies from the single spores. 
Expression validation of the FLAG-tagged CPVIB-1 vector construction and
phenotype testing 
Phenotype recovery assay
Fungal strains (EP155 wild type strain is isogenic to Dcpvib-1 and the positive
FLAG-tagged CPVIB-1 strains) were cultured on PDA plates for 7 days to encourage
hyphae growth at room temperature in the same environment. In brief, the same size
plugs with mycelium from PDA plates were inoculated on the same set of PDA plates.
Vegetative incompatibility assay
The vegetative incompatibility assay was designed by Lynn Geletka to test the
ability of hyphae of different strains to fuse and exchange cytoplasm [116]. The strategy 
of pairing the above three strains (EP155 wild type strain, its isogenic Dcpvib-1 strain and 
the positive FLAG-tagged CPVIB-1 strain) and their compatible (EU5) and incompatible
strains (EU5) of C. parasitica was described in Chapter I. All of the above five strains were
firstly revived on PDA plates for 5 days in order to obtain the fresh condition mycelium. 
Small plugs (4 mm2) with mycelium were cut from all of the above five strains and paired 
with 3 mm separation between the two strains on BGA Medium (Table 5.1). One petri dish 
contains approximately 45 ml of BGA medium. The plates were then incubated in the dark 
for 4 days at room temperature and exposed to the light for another 2 or 3 days on the





        
     
     
      
         
      
        
       
        
       
        








The three strains (EP155 wild type strain, its isogenic Dcpvib-1 strain and the
positive FLAG-tagged CPVIB-1 strain) were started on PDA plates for 5 days again to 
obtain the fresh same condition mycelium. First, bark indentations (6 mm in diameter) were
drilled into the American chestnut stems (C. dentata) approximately 20 cm apart from each 
other. Second, the mycelium plugs (6 mm in diameter) of three strains drilled from the PDA
plates were inoculated into the indentations. Third, parafilm was wrapped around the
wound with the inoculation of the fungus to prevent desiccation. At the end, the stems
inoculated with three replicates of each of the three strains were kept in a clean container 
at room temperature for 21 days. After that, the ovate infection areas with the mycelium
growth were traced on a piece of semi-transparent paper, cut out and weighed to measure
the extent of the infection area. The statistics analysis of variance (ANOVA) was used to 
evaluate the measurements using avo package in R. Another R package ggboxplot were
used to assist the analysis and display the results. 
Western blot assay
The mycelial plugs from the fungal strains to be tested were inoculated on PDA
plates for 5 days to obtain fresh mycelium. Plugs from these were then cultured in PDB 
broth on the bench, stationary and at room temperature, for four days. After 
homogenization and re-growth to achieve log phase fungal cells for total protein 
extraction, they were harvested by filtration through Miracloth, and then immediately 
ground into a fine powder by using a sterilized mortar and pestle [51]. If rapamycin was
included, it was added at a concentration of 10 ng/ml immediately after homogenization.














ratio of 1:2 (2 ml the Protein Extraction Buffer per 1 g mycelium powder) with 50 µl 
protease inhibitor cocktail for yeast (Sigma, USA) per 1 g mycelium powder. The above
mixture was vigorously vortexed for 15 seconds and incubated on ice for 30 mins with 
the above vortex and incubation one additional time. The mixture was then centrifuged at
maximum speed (14,000 xg) for 15 minutes at 4°C.
The extracted total protein samples were mixed with a 1x final concentration of 
LDS sample buffer (Invitrogen) with the addition of b-mercaptoethanol (4 %) per 
manufacturer’s instructions, boiled for 4 minutes and loaded on a precast 10% 
polyacrylamide gels (Bio-Rad Laboratories, Inc., USA) in TGS running buffer. The
proteins separated in polyacrylamide gel were then transferred to an Immobilon-P 
membrane (Millipore, USA) using a Trans-Blot SD semi-dry electrophoretic transfer cell
(Bio-Rad Laboratories, Inc., USA) using Transfer Buffer at 18 volts for 45 minutes. The
membrane was briefly washed with distilled water and allowed to dry. After wetting in 
100% methanol, the membrane was placed in a 5 % nonfat dry milk block (Bio-Rad 
Laboratories, Inc., USA) prepared in the TBST for 1 hour at room temperature or 
overnight at 4 °C. The membrane was briefly washed in the TBST and incubated in a
1:1000 dilution of a-FLAG monoclonal (Sigma, USA), 1:1000 dilution of a-FLAG 
monoclonal (Sigma, USA), 1:5000 dilution of anti-beta actin (Abcam, USA) primary 
antibody or 1:1000 dilution of anti-ubiquitin antibody (Cell Signaling Technology, USA) 
for 2 hours at room temperature. The membrane was washed three times in the TBST for 
5 minutes prior to incubation in a 1:2000 dilution of HRP-Goat Anti-mouse (Bio-Rad 
Laboratories, Inc., USA) secondary antibody for 1 hour at room temperature. FLAG-












   
  
 






Laboratories, Inc., USA) and imaged on a Chemi-doc Imager (Bio-Rad Laboratories, 
Inc., USA).
For the purpose of the detecting only ubiquitinated proteins, the membrane was
then stripped with a 0.5 M NaOH solution for 15 minutes at room temperature with a
gentle shaking process and rinsed three times using TBST buffer. Subsequently, the
membrane was re-blocked with 5% nonfat milk and the exact same procedure above
followed with the substitution of the Anti-Ub antibody (Cell Signaling Technology, Inc., 
USA). 
Growth rate assay of nutrient starvation and rapamycin treatment on the EP155 
and Dcpvib-1 strain
The mycelium plugs from the EP155 wild type strain and its isogenic Dcpvib-1
strain were inoculated on PDA plates for 5 days to obtain the same condition mycelium. 
The same size fresh mycelium plugs (4 mm in diameter) from above were then cultured 
in minimal defined media EMM (Edinburgh Minimal Media, Sunrise Science, USA), 
Full Medium (Add 20 g glucose and 5 g NH4Cl per liter) plates, EMM-Low glucose (Add 
5 g glucose and 5 g NH4Cl per liter) plates, or EMM-No Nitrogen (Add 20g glucose and 
0g NH4Cl per liter) plates, all on the bench at room temperature for 7 days and all with or 
without 10 ng/mlrapamycin (Cayman chemical, USA). The diameters of the mycelium
growth area were measured using a micrometer each day to calculate the growth rate in 
millimeter per day unit. The ggplot2 package of R was used to visualize the growth rate

















   
  
    
  
The viable cell measurement (MTT) assay of rapamycin treated mycelium
The effects of the rapamycin on cell viability of C. parasitica was detected by 
using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay 
following the protocol from Patel [117]. Both the EP155 wild type strain and its isogenic
Dcpvib-1 strain were cultured in PDB broth for 4 days and harvested from the lower layer 
containing loose filamentous hyphae. Next, 50 ml of PB Buffer was used to rinse and 
remove residual media. Small pieces mycelium was weighed and inoculated into PB 
Buffer with and without 10 ng/mlRapamycin for 16 hours at room temperature.  All
mycelium cells were collected, rinsed with 10ml PB Buffer for 4 times and merged in the
MTT Solution for the viable cells reacting with MTT to produce a purple colored 
formazan at 30 °C with shaking for 90 minutes. After centrifuged for 10 minutes for cell
collection, the MTT Solution was removed completely and 800 µl MTT solvent was
added to dissolve the purple formazan. A Gen5 Microplate Reader was used to measure
the absorbance (A570) of each sample (9 samples for each stain in each treatment) [117]. 
All results were statistically analyzed using one-way ANOVA test using the avo package
of R.
ChIP-sequencing
The mycelial plugs from the Dcpvib-1 strain and its isogenic positive FLAG-
tagged CPVIB-1 strain were inoculated on the PDA plates for 5 days to obtain the same
condition mycelium. Three biological replicates of the Dcpvib-1 strain and six biological






   












PDB broth for 4 days and homogenized. 10 ng/ml Rapamycin for treatment was added to 
three of the six FLAG-tagged CPVIB-1 strain cultures. 
Next day, all of the above mycelium were harvested and fixed using 1 % 
Formaldehyde Solution (PierceTM 16 % Formaldehyde, Methanol-free suspended in 1X
PBS, Thermo Fisher Scientific, USA) for 10 minutes on a platform shaker at 100 rpm at
room temperature. Subsequently, 2.5 M glycine was used to quench the formaldehyde to 
a final concentration as 0.1 M for 5 minutes on the same platform shaker. After that, all
mycelium was harvested on Miracloth, and then immediately washed by 1X PBS for 
three times. 
The total protein extraction was performed using the similar protocol mentioned 
above but replacing the vigorous vortex step with gentle rotation for 1 hour at 4°C to 
minimize dissociation of the protein-DNA complex. For each 1 ml total protein solution, 
3 µl of 1M CaCl2 and 5 µl of micrococcal nuclease (MNase, NEB, USA) was added, and 
incubated for 20 minutes in a 37°C water bath with mixing every 2 minutes by inversion 
to digest the chromatin into small fragments. To stop the reaction and prevent over 
digestion, 6 µl of 0.5M EGTA (pH 8.0) was added. Next, the samples were filtered by 
0.22 µm filter to remove any remaining cell debris and particulates that may interfere
with protein immunoprecipitation and 140 µl of 1M NaCl was added to minimize
nonspecific protein binding. 
For each 1 ml nuclease digested protein-chromatin solution, 40 µl of the ANTI-
FLAG M2 Magnetic Beads (Sigma, USA) was used to capture and precipitate the FLAG-

















manufacturer’s instruction manual. These were then eluted using a 0.1 M Glycine HCl, 
pH 3.0 elution protocol. 
To the protein-chromatin solution, 5 µl of RNase A, DNase and protease-free 10
mg/ml (Thermo Fisher Scientific, USA) was added to a final working concentration 
100ug/ml and incubated at 37°C water bath for 30 minutes. Subsequently, the solution 
was boiled for 10 mins and then incubated at 48°C water bath for overnight with 8µl
Proteinase K (NEB, USA) to reverse the crosslinking by digesting the protein and release
the DNA fragments. 
ChIP DNA Clean& Concentrator Kits from Zymo Research was used to purify 
the DNA fragments from the above solution. 5 volumes of ChIP DNA binding buffer 
from the kits were used based on the DNA solution volume from the last step. 20 µl of 
1X TE Buffer was used to elute the DNA from all columns of each biological replicate. 
The concentrations of the purified DNA fragments were examined using Qbit
Fluorometer (Invitrogen, USA) and dsDNA HS Assay Kit (Invitrogen, USA).
NEBNext® Ultra™ II DNA Library Prep Kit for Illumina® (NEB, USA) was
used to prepare the ChIP DNA library using at least 1.5 ng input amounts (Table
5.2). Three steps were modified. First, in the Adapter Ligation step, instead of using 
25-Fold (1:25) dilution in Tris/NaCl, pH 8.0, 50-Fold (1:50) dilution was used for all
samples after the optimization in my experiment to prevent the adapter self-ligation 
from composing the major portion of the library. Second, in the PCR Enrichment of 
Adapter-ligated DNA step, both the Index Primer/i7 Primer and Universal PCR 




















NEBNext Ultra II Q5 Master Mix cut to 20 µl to avoid primer-dimer formation. 
Third, the number of PCR cycles for each sample was pre-optimization and set at 18. 
The Illumina HiSeq2500 platform was used to sequence six samples of the
ChIP-Seq DNA library from three replicates of the FLAG-tagged-CPVIB-1 and from
three replicates of FLAG-tagged-CPVIB-1-Rapamycin using Illumina V4 chemistry 
and paired end 150 cycle reads. The sequencing was performed by Genewiz, Inc., 
(South Plainfield, NJ).
Bioinformatics analysis
The first step of the ChIP bioinformatics analysis was to use FastQC to perform
the quality assessment of each sequencing file. Second, Trimmomatic and the
adapter/primers database from the NEBNext Ultra™ II DNA Library Prep Kit was
performed because the results from FastQC indicated that the existence of the low
qualities of the nucleotides and the possible presence of NEB adapters and primers [83]
with the SLIDINGWINDOW and MINLEN parameters setting as 4:25 and 36, 
separately. Third, Bowtie2 was used to align all reads using default parameters to the C. 
parasitica reference genome to generate a sequence alignment/map (SAM) format file
composed of alignment information including the short reads ID, scaffold name, 
coordinate information, mismatch information, and the raw nucleotides of the read, 
among others [84].  Fourth, grep function command (grep –v “XS:i:” alignment_file.sam
> alignment_file_unique.sam) was used to extract the reads that were only aligned to the
genome uniquely. Fifth, Model-based Analysis of ChIP-Seq version 2 (MACS2) was 

















   
 
   
   
 
adjust read position based on fragment size distribution, calculate peak enrichment using 
local background normalization by running the ‘callpeak’ function by setting the genome
size at 50 Million based on the C. parasitica genome assembly size, the minimum false
discovery rate (FDR) q-value cutoff for peak detection at 0.01 and the fold-enrichment
cutoff value at 3 to greatly eliminate the possibility of calling the false binding peaks of 
the CPVIB-1 protein [118].  The command used for MACS2 callpeak is listed here
(macs2 callpeak -t all_biological_replicates.bam -c all_vib1_replicates.bed -g 50000000 -
n outputfile_cpvib-1 -q 0.01 --fe-cutoff 3.0 -B --nomodel --trackline --verbose 3). Finally, 
Hypergeometric Optimization of Motif Enrichment (HOMER) version 4.10, a suite of 
tools for motif discovery (findMotifsGenome.pl) and annotation analysis
(annotatePeaks.pl) was used to identify the recognition sequence of the CPVIB-1 protein 
and annotate the potential target genes of the CPVIB-1 protein with default parameters
[119]. Both HOMER tools have the advantage to take the custom genome and annotation 
files, which can be applied to all non-model organisms rather than the built-in model
organisms.
Results
Validation of functional substitution and expression of the FLAG-tagged CPVIB-1
for CPVIB-1
As discovered by Rong Mu and described in Chapter I, the Dcpvib-1 strain shows
profuse sporulation and reduced aerial hyphal growth compared to its isogenic EP155 
strain (Figure 5.1). By contrast, with the FLAG-tagged CPVIB-1 expression vector 
transformed into the Dcpvib-1 strain, the phenotype was recovered partially with increase



















   
 
difference to the use of a non-native promoter to drive expression of the FLAG tagged 
CPVIB-1.
The vegetative incompatibility assay was designed by culturing fungal mycelium
plugs in close proximity (2~4 mm apart) on BGA Medium. Compatible colonies will fuse
to create a uniform structure that becomes indistinguishable from a single colony grown 
alone. In C. parasitica, vegetative incompatibility between incompatible colonies can be
seen by the production of a barrage where the colonies meet on BGA Medium. In the
same study from Rong Mu in the Chapter I, the Dcpvib-1 strain was found to regulate the
vegetative incompatibility of EP155 and EU1, which have different alleles at the vic4
locus, when using this assay (Figure 5.2, A). However, with the deletion of cpvib-1 from
both strains, the absence of barrage in the vegetative incompatibility assay indicated they 
were compatible with each other (Figure 5.2, B). Based on this background, the positive
FLAG-tagged CPVIB-1 strain was tested using the vegetative incompatibility assay with 
the EU1-Dcpvib-1 strain (Figure 5.2, C).  The barrage formation was observed in the
BGA Medium that indicated the proper operation of the FLAG-tagged CPVIB-1 protein 
(Figure 5.2, C).
Rong Mu also discovered that the deletion of cpvib-1 caused a large reduction in 
virulence of C. parasitica. In this study, the virulence assay of three strains (EP155 wild 
type strain, Dcpvib-1 strain and FLAG-tagged CPVIB-1 strain) was performed on the
American chestnut stems with five replicates for each strain. The cankers display of the
virulence assay from these three strains indicated the virulence recovery of the FLAG-
tagged CPVIB-1 strain (Figure 5.3). By utilizing the one-way ANOVA test to analyze the





    












   
significantly differences of canker size between any two strains with a p-value < 0.01. 
The R package ggboxplot was used to display the cankers size numerical data categorized 
by strains (Figure 5.4). The virulence assay showed that the canker sizes of the positive
FLAG-tagged CPVIB-1 strain were significantly larger than the Dcpvib-1 strain and close
to the EP155 wild type strain. Both the phenotype assay and virulence assay results
confirmed the functional substitution of FLAG-tagged CPVIB-1 for CPVIB-1 in C. 
parasitica.
In the end, western blots were used to confirm the expression and detectability of 
the FLAG-tagged CPVIB-1 protein by the anti-FLAG antibody with the expected 72KDa 
size band (Figure 5.7, Figure 5.8) An additional band higher than 75KDa protein standard 
(Figure 5.6, Figure 5.7, Figure 5.8) was also detected and is further described next
section.
Rapamycin acts through a CPVIB-1-related pathway
Rapamycin induces cell death through CPVIB-1 
In EP155 strain, with CPVIB-1 protein present, the viable cell rate in 10 ng/ml
rapamycin group was 27.15 % of the control group from the MTT viable cell
measurement assay. In contrast, in the Dcpvib-1 strain without the presence of CPVIB-1 
protein, the viable cell rate was 63.83 % on average under the same rapamycin treatment
(Figure 5.5). The results were statistically significant differences based on a t-test 
analysis (p-value < 0.001). Thus, the induced cell death rate of 10 ng/ml rapamycin was







   
















Rapamycin increases accumulation of the FLAG-tagged CPVIB-1
The FLAG-tagged CPVIB-1 protein accumulation level was detected by western 
blot for cultures grown in both EMM full Medium and 10 ng/ml rapamycin 
treatment/EMM full Medium (Lane 1 and 2, Figure 5.6). Rapamycin treatment increased 
the FLAG-tagged CPVIB-1 protein accumulation (Lane 1 and 2, Figure 5.6), consistent
with the western blot assay of the positive FLAG-tagged CPVIB-1 strain cultured in PDB 
and 10 ng/ml rapamycin treatment PDB (Lane 1 and 2, Figure 5.7). However, the
detectable protein bands were larger than the predicted size (72 KDa) and less abundant
than expected when using 25 µg total protein (Figure 5.6).
CPVIB-1 is ubiquitin decorated
Based on the unexpectedly large detected protein bands from the western blot
assay and the multiple positive ubiquitination sites prediction of the CPVIB-1 protein 
sequences using UbiSite (http://csb.cse.yzu.edu.tw/UbiSite/), it was hypothesized that
CPVIB-1 could be ubiquitinated which might lead to its degradation in ubiquitin 
proteasome system. It is the principle mechanism for protein catabolism in cytosol and 
nucleus including the degradation of the transcriptional regulators like CPVIB-1 [120]. 
The results of the western blot assay using 80 µg total protein showed two detectable
protein bands by anti-FLAG antibody, one above the 75 KDa marker that was identified 
previously in last step, the other below the 75 KDa marker and closer to the predicted 
size of 72 KDa (Lane 1 and 2, Figure 5.7). Interestingly, rapamycin treatment increased 
the accumulation of FLAG-tagged CPVIB-1 protein, and the upper band with the












     
 
 







Using immunoprecipitated FLAG-tagged CPVIB-1 proteins in a western blot
assay with the anti-FLAG and anti-ubiquitin antibody, only the upper band was detected 
using anti-ubiquitin antibody, but the two band were still detected using the anti-FLAG 
antibody (Figure 5.8). 
The connection between CPVIB-1, the nutrient starvation, and rapamycin
treatment 
The growth inhibition caused by rapamycin in C. parasitica is related to CPVIB-1 and 
the nitrogen starvation response
The growth rate of EP155 strain and its isogenic Dcpvib-1 strain was decreased 
most in the low-glucose medium with or without the presence of rapamycin (Table 5.3). 
The EP155 strain was found more to be sensitive to the treatment of rapamycin compared 
to the Dcpvib-1 strain (Table 5.3). The growth rate differences of two strains between 
treatments in EMM full medium condition suggested the growth inhibition caused by 
rapamycin was affected by the presence of CPVIB-1 gene (Table 5.3). This rapamycin 
growth inhibition affect was enhanced under the nitrogen starvation environment to the
EP155 strain compared to the Dcpvib-1 strain (Table 5.3). However, the same
phenomenon was not found in both glucose and nitrogen starvation environment (Table
5.3).
The glucose starvation environment stimulates accumulation of the FLAG-tagged 
CPVIB-1
Western blot assay was used to the detect the FLAG-tagged CPVIB-1 protein 
accumulation level from the FLAG-tagged CPVIB-1 transformed strain in both EMM
full Medium and EMM-Low glucose Medium. The results suggested that the

















starvation condition (Lane 1 and 3 Figure 5.6). However, the nitrogen starvation 
treatment was found not to increase the FLAG-tagged CPVIB-1 protein accumulation 
level (Lane 1 and 5, Figure 5.6). 
ChIP-sequencing reveals the binding recognition sequence motif and downstream 
genes of CPVIB-1
Quality assessment of ChIP-Seq reads
The ChIP DNA libraries were sequenced using the Illumina paired end 
sequencing technology, generating 32 to 83 million reads for six samples (Table 5.4) with 
the existence of poor quality nucleotides and NEB adapters detected using FastQC 
(Figure 5.9 (A)). With the application of Trimmomatic to remove the poor-quality 
nucleotides and NEB adapters, there were about 16 to 26 million remaining paired reads
for each sample (Table 5.4). After the alignments and removal of reads that mapped to 
multiple locations, the single-locus mapped reads from three biological replicates of one
group were combined together in BAM format to be used to call the peaks that were
bound by FLAG-tagged CPVIB-1 protein. 
Quality assessment of DNA fragments distribution, peak calling and regulated genes
identification.
The first step of a general ChIP-Seq bioinformatics analysis is to remove the PCR 
duplicates. This is critical because of the low amount input DNA for preparing the library 
in this study [121]. However, most tools designed to perform the redundant reads
removal were for sonication fragmentation projects rather than nuclease fragmentation as
used in this work. However, by default MACS2 was designed to serve this goal through 














   
  
 
   
 
After this step, there were 2.69 million and 0.823 million reads retained from the FLAG-
tagged-CPVIB-1 (untreated) and the FLAG-tagged-CPVIB-1-Rapamycin (treated) 
samples, respectively (Table 5.4). 
The second step was to adjust read position based on fragment size distribution 
because the sequenced DNA reads from a ChIP library are often only encompassing the
minimal DNA fragments spanning  the protein-DNA interactions [118]. Since the
sequencing technology is likely to sequence the 5’ end of the both strands, the reads
mapped to genome appear to be at the left or right side of the protein-DNA interaction. 
Therefore, the reads density around a true binding site should show a bimodal enrichment
pattern, with forward strand tags enriched upstream of the binding site and reverse strand 
tags enriched downstream [118]. MACS2 is a model-based analysis tool designed to 
capture the reads that represent the ends of the fragments in a ChIP-DNA library and 
determine the reads that are responsible for peak calling. Both the FLAG-tagged-CPVIB-
1 and the FLAG-tagged-CPVIB-1-Rapamycin samples showed the expected bimodal
pattern (Figure 5.10). The d value of 128 and 112 bp for both samples represents the
estimated distribution of DNA fragment size (Figure 5.10), a typical value for 
transcription factors and critical to extend the ChIP-Seq reads to accurately represent the
original ChIP protein-DNA binding sites [118]. 
The third step is to calculate peak enrichment using local background 
normalization. As recommend by a comparison report of the tools designed for ChIP-Seq
analysis, MACS2 was selected because it was designed to perform peaks calling step 
without the requirement of an input control sample [122]. The strategy is to model the
















parameter that varies along the genome to differentiate the peaks from the genome
background [118]. In this study, the control samples (from strain Dcpvib-1, thus a strain 
with no FLAG-tagged protein to recover) failed to generate sufficient DNA input for 
sequencing, which makes the MACS2 the best analysis tool for our project. Meanwhile, 
the parameters of fold-change and q-value (minimum FDR, false discovery rate) was set
at 3 and 0.01 to reduce the possibility of false positive peaks calling. There were 275 and 
358 peaks were called in the FLAG-tagged-CPVIB-1 and the FLAG-tagged-CPVIB-1-
Rapamycin samples, separately (Table 5.5). One example of the peak that was identified 
as a binding site of FLAG-tagged CPVIB-1protein in PDB broth and rapamycin 
treatment is shown in Figure 5.11 (A). A second example of a peak only detected as a
binding site of FLAG-tagged CPVIB-1 protein in PDB broth is shown in Figure 5.12 (B). 
A peak that was only detected as a binding site of FLAG-tagged CPVIB-1protein in 
rapamycin treatment is shown in Figure 5.11 (C).
Recognition sequence analysis
To reveal the FLAG-tagged CPVIB-1protein recognition sequences from the 275 
and 358 peaks called in the last step, the HOMER program was used to extract sequences
from the genome corresponding to the peak regions, auto-normalize the sequence bias by 
building the background automatically and check the enrichment of known recognition 
sequences of genes from its reliable library, as well as find the de novo recognition 
sequences of length less than 8 bp [119]. 
In the FLAG-tagged CPVIB-1 samples, the recognition sequence GAGAGAGA 
(Reverse Complementary: TCTCTCTC) was identified as the top candidate with a p-










    
   
   
   
 
  





between recognition sequence center and all the peak summits was calculated to 
determine its specific position within the peaks (Figure 5.12 (B)). A consistent feature for 
the transcription factors described in other studies was that the majority of recognition 
sequences were located within the summit region of peaks[109; 119] as was the case in 
the FLAG-tagged-CPVIB-1 sample data. In addition, by searching the similar recognition 
sequences in HOMER library, five well-studied proteins were found to bind similar 
recognition sequences with significant low p-values (Table 5.6) and their recognition 
sequences are shown in Figure 5.12 (C). The top candidate protein identified to share the
similar GAGAGAGA recognition sequences is BPC6, which was identified as a
transcriptional regulator involved in developmental processes in Arabidopsis thaliana 
(Figure 5.12 (C)) [112]. This GAGAGAGA recognition sequences was identified with an 
p-value of 1e-30 and exists in 58 out of the 275 (21.09%) peaks in the FLAG-tagged-
CPVIB-1 samples (Figure 5.12 (C)). Another three known genes are FRS9, a putative
transcription activator involved in regulating light control of development, BPC1, a 
transcriptional regulator involved in developmental processes and a GAGA-repeat
binding protein that were also shown to have a highly similar GAGA recognition 
sequence (Figure 5.12 (C)) [123-124]. The other known protein, VRN1 is a T-repeats 
element binding transcriptional repressor of FLC, a major target of the vernalization 
pathway (Figure 5.12 (C) [125].
In the FLAG-tagged-CPVIB-1-Rapamycin samples, the recognition sequence
GG[A]A[C]AGA[G]A[G]G (Reverse Complementary: CT[C]T[C]CTT[G]C[T]C[T]) 
was identified as the top candidate with a p-value of 1e-7 and exists in 116 out of 357 

























all the peak summits were calculated as well (Figure 5.13 (B)). The majority of this
recognition sequence located within the central region of peaks in the FLAG-tagged-
CPVIB-1-Rapamycin sample as well but with a diffusion distribution towards the nearby 
regions [109; 119]. In addition, scanning the HOMER library identified five well-studied 
proteins that were found to bind similar recognition sequence with significant low p-
values (Table 5.7) and their motifs are shown in Figure 5.13 (C). With an p-value of 1e-7, 
the top candidate was identified to be KLF10, which is a transcriptional repressor that
acts as an effector of transforming growth factor beta signaling in Homo sapiens (Figure
5.13 (C)) [126]. The same GGGGGT[C]GTGT[G]C[G]C[T] recognition sequence of 
KLF10(Zf) exists in 27 out of the 357 (7.56%) peaks in the FLAG-tagged-CPVIB-1-
Rapamycin samples (Figure 5.13 (C)). Another three known proteins, FRS9, BPC6 and 
GAGA-repeat were identified in the FLAG-tagged-CPVIB-1 samples as well (Figure
5.13 (C)) [112; 123]. The other matched protein that was unique in the rapamycin 
treatment samples sharing a similar GAGA-repeat recognition sequence, TRL is a
transcriptional activator to promote the open chromatin conformation to allow the access
to other transcription factors (shown in Figure 5.13 (C)) [111].
Functional annotation of FLAG-tagged CPVIB-1 targeted genes
HOMER was used to annotate the location of the peaks in terms of important
genomic features, such as transcription start site (TSS), transcription termination site
(TTS), exon (Coding region), 5’ UTR, 3’ UTR, intronic, and intergenic using the C. 
parasitica genome and the most recent 2017-version annotation [119]. For the FLAG-
tagged CPVIB-1 samples, 264 out of 275 peaks were annotated to be in the genomic
















   
   
 
program REVIGO was used to visualize the biological processes of the targeted genes of 
FLAG-tagged CPVIB-1 protein (Figure 5.14). The highlighted GO term with the highest
peak-score was GO:0000753 Cell morphogenesis, involved in conjugation and cellular 
fusion and its related gene is Ep155_U_T00007121. This is similar to the FIG1 gene
from Saccharomyces cerevisiae, responsible for cell-cell communication, cell fusion 
(Figure 5.14) [127]. The second group of clustered GO terms we are interested in were
the GO:0006914 autophagy and GO:0042981 regulation of apoptotic process, thus both 
involved in the programmed cell death pathways. The other GO term cluster groups were
highlighted to represent the variety of genes involved in different biological processes, 
such as meiosis, metabolism, transport, transcription, translation and post-translation 
(Figure 5.14).  
In order to investigate the expression profile of the FLAG-tagged CPVIB-1 
targeted genes, the transcriptome data from Chapter IV that compared the EP155 wild 
type and Dcpvib-1 mutant strains were utilized. There were 118 out of the above 264 
genes significantly altered in the Dcpvib-1 mutant strain suggested that about half of the
observed targets of FLAG-tagged CPVIB-1 protein had their transcription process
directly modulated. The GO term distribution of these 118 genes were also visualized 
using REVIGO [92]. The highly important GO terms mentioned above, such as, cell
morphogenesis involved in conjugation, regulation of apoptosis, meiosis, metabolism, 
transport and transcription were found to be significantly altered in transcriptional level
(Figure 5.15). In addition, several GO terms were highlighted to be significantly 
regulated in the Dcpvib-1 mutant strain included proteolysis, carbohydrate metabolism




















With rapamycin treatment, 292 out of 358 peaks were annotated to be in the
genomic features (Table 5.5). The majority of their GO terms were similar to the non-
rapamycin treated FLAG-tagged CPVIB-1 samples, but the unique ones that were
presenting with the rapamycin treatment are shown in Figure 5.16. most interestingly, 
these include GO:0031929 TOR signaling, which was linked to gene
Ep155_U_T00000852 with a function similar to STE20 (target of rapamycin complex2 
subunit) in Schizosaccharomyces pombe (Figure 5.16). Also, the GO terms with highest
peak scores were the phosphorylation and phosphorelay signal transduction systems. In 
addition, the protein repair, sterol metabolism, exocytosis and cell redox homeostasis
were highlighted after rapamycin but not were not present in the untreated analysis
(Figure 5.16). Of the 292 genes, 121 were significantly regulated at the transcriptional
level by CPVIB-1 from the transcriptome comparison data. In the GO terms cluster 
distribution plot, they were all overlapped with the GO terms from the targets the FLAG-
tagged CPVIB-1 (untreated) samples (Figure 5.17). 
In the 264 genes targeted by FLAG-tagged CPVIB-1 and 292 genes targeted by 
FLAG-tagged CPVIB-1 with rapamycin treatment, 21 of them were same genes from
them and the others were unique based on the treatment (Table 5.5). All of them are listed 
with their UniProt ortholog protein names, the log2 fold change value in the
transcriptional level in the absence of CPVIB-1, and the GO terms and biological
processes they involved in (Table 5.8). Among them, the apoptotic regulation gene
(YBR241C), the glucose metabolism gene (cfp, pyruvate decarboxylase), the oxidation-
reduction process (mutM), the mRNA degradation process (dom34, RNA surveillance) 





















   
in the mutant Dcpvib-1 strain, such as the reduced hyphal growth, the reduced virulence
and reduced programmed cell death. Moreover, a transcriptional regulator named SIM1 is
a protein involved in the control of the apoptosis-like cell death and telomere length 
homeostasis with CDC13 in S. cerevisiae [128]. 
Discussion
As a preparative step to revealing the targets of CPVIB-1 in this study, the FLAG-
tagged CPVIB-1 was expressed and shown to functionally complement the C. parasitica
Dcpvib-1 mutant strain, and to be recoverable by immunoprecipitation. During this work, 
CPVIB-1 was found to be decorated by ubiquitin which might lead to the degradation of 
CPVIB-1 through the ubiquitin-proteasome system (UPS). UPS is a universal regulation 
system shown to control the localization, abundance and activity of transcription factors
[129]. As one of the principal mechanism for protein catabolism, the UPS regulates the
abundance of the transcription activators by covalently tagging the proteins with multiple
ubiquitin molecules (Conjugation), and subsequently degrading the tagged proteins via
the proteasome activity (Degradation) [120; 130]. Based on the bands migration 
compared to the protein molecular weight standards, we estimated that the mass of 
ubiquitin modified FLAG-tagged CPVIB-1 protein to be approximately 22 KDa larger
than the predicted size and much more abundant led to the hypothesis that the CPVIB-1 
protein was associated with multiple ubiquitin modifications at one or various sites or 
other types of post-translation modification. 
CPVIB-1 was found to be induced by rapamycin and carbon starvation treatment. 
















discovered to be able to mimic the incompatibility reaction by targeting the TOR (target
of rapamycin) signaling pathway, which has the TOR protein kinase (conserved from
humans to yeast) to control cell growth in response to nutrient availability [104-105]. 
Generally, rapamycin inhibits the TOR signaling pathway leading to the autophagy, 
expression of starvation-induced genes and inhibition of translation in yeast and other 
organisms [102; 105].  Therefore, rapamycin was hypothesized to be a promoter for the
expression of CPVIB-1 to induce programmed cell death.  To test this hypothesis, the
viable cell number in the rapamycin treated and untreated were measured using the MTT
assay, the hyphal growth rate in the rapamycin treated, nutrient starvation treated and 
untreated were measured, and the accumulation level of FLAG-tagged CPVIB-1 in the
rapamycin treated, nutrient starvation treated and untreated samples was detected.  
The viable cell number in rapamycin treated mycelium was significantly reduced 
compared to the control indicating the same inhibition mechanism of cell growth through 
TOR pathway in C. parasitica as was observed for P. anserina. Second, without the
presence of CPVIB-1, the ability of rapamycin to trigger cell death was reduced, 
indicating the relationship between the CPVIB-1 and rapamycin action. Third, the hyphal
growth rate inhibition of the rapamycin treatment was reduced without the presence of 
CPVIB-1 compared to EP155 strain. Lastly, the accumulation level of FLAG-tagged 
CPVIB-1 protein in the rapamycin treated tissue was clearly increased compared to the
control confirming that CPVIB-1 is induced by rapamycin treatment. Under the nutrient
starvation environment, the TOR signaling pathway was inactivated leading to the similar 
outcomes for rapamycin treatment in P. anserina [105]. Therefore, in C. parasitica, the














     
rate assay and the western blot assay. The growth rate under the glucose starvation but
not nitrogen starvation was significantly reduced compared to the full defined medium. 
Similarly, without the presence of CPVIB-1, the growth rate inhibition of rapamycin 
treatment under either of the nutrient starvation was also reduced indicating both 
rapamycin and nutrient starvation inactivate the TOR signaling pathway. Furthermore, 
while nitrogen starvation did not induce CPVIB-1 expression, the glucose starvation was
found to increase the accumulation of CPVIB-1 similar to the rapamycin treatment. The
related actions of CPVIB-1 and rapamycin present the clear association of regulatory 
mechanisms controlling the TOR signaling pathway.
With current technology, ChIP-Seq is the most widely used strategy to explore the
protein-DNA interaction sites, and is suitable for the goal of this study to identify the
targets of a transcriptional factor [131]. In this study, the ChIP DNA library prepared 
from the FLAG-tagged CPVIB-1 samples was sequenced for this purpose. Meanwhile, 
the FLAG-tagged CPVIB-1 rapamycin treatment samples were prepared to induce the
expression of CPVIB-1 and sequenced as well to explore the possibility of the treatment
leading to differential targets and potentially reveal the regulatory relationship of TOR 
and CPVIB-1. Unfortunately, it was impossible to obtain enough background input DNA
for the negative control probably due to the high specificity of the ANTI-FLAG antibody 
under the 160 mM sodium salt lysis solution, which is recommended for the high 
specificity binding. As for the quality of the sequencing, 16 to 26 million reads were
obtained for each biological replicate after the stringent trimming process (Table 5.4). 
ENCODE ChIP-Seq guideline recommended that 20 million reads are suitable for 



















were ample high-quality DNA reads for our project based on the relatively small genome
size [131]. Because of the absence of the background input negative control, the peak-
calling process was set with the extremely harsh parameters to eliminate false discovery. 
For both the FLAG-tagged CPVIB1 sample and its rapamycin treated sample, the GA-
rich element was revealed to be the recognition sequence of CPVIB-1 protein. By 
searching the similar motif binding genes against the HOMER database, several
transcriptional regulators with the same GA-rich motif binding feature were identified. 
They were BPC1, BPC6, FRS9 and VRN1, three GAGA-biding transcriptional regulators
in Arabidopsis plus the TRL and GAGA-repeats factors, two transcriptional regulators in 
Drosophila [111-112; 123-125]. 
Therefore, we conclude that CPVIB-1 is functionally a GAGA-repeats binding 
transcriptional regulator (GAF) in C. parasitica that functions in remarkably diverse
range of regulatory contexts, including activation/repression of genes’ transcription, 
mitosis maintenance, cell development, and autophagy, cell-cell communication, 
virulence, nucleosome assembly, etc. In other systems, GAF transcriptional regulators
were found to be responsible for the activation and silencing of gene expression by 
specific binding to the promoter regions of various genes, including homeotic genes
during developmental stages [96]. In this study, CPVIB-1 was found to target 275 genes
distributed in various biological processes and significantly altered about half of them at
the transcription level. These processes included mitosis, biosynthesis, metabolism, 
autophagy, cell fusion, and translation, which are consistent with the roles found from










    
  







CPVIB-1 targets at least six important regulators. SIM1 is involved in the control
of the apoptosis-like cell death and telomere length homeostasis [128], which correlates
with the function of CPVIB-1 to maintain pathogenesis that was observed in both 
Chapter I and IV. Epithelial mesenchymal transition (EMT) plays roles in altering cells to 
a mesenchymal cell phenotype [135]. Proteasome regulator is an essential component of 
the ubiquitin-proteasome system [130]. GTPase signaling regulator activates GTPase
signaling pathway and involves in the virulence [136-137]. CRZ1 regulator is essential
for the pathogenicity by regulating the calcium signaling and high-osmolarity glycerol
response (HOG) signaling pathway [109; 138]. In the end, SAP30 regulator was
discovered to be a component of histone deacetylase complex, which involved in 
telomere maintenance and the infectious growth of rice blast fungus [139]. 
Furthermore, GAFs have been found to act as more than a typical transcriptional
factor but also the genome-scale transcriptional regulator by facilitating the formation 
and maintenance of nucleosome free regions of the chromatin to expose the promoter 
sequences for the access of other transcriptional factors [111]. In this study, the target
genes of CPVIB-1 include the DNA helicase for the mitosis, telomere maintenance and 
the decomposition of the chromatin complex and the activators for the transcription of 
RNA polymerase II promoter for the promotion of the transcription process [140-142]
(Figure 5.15), all of which would fit with this role. In conclusion, CPVIB-1 is a GAGA-
motif biding transcriptional regulator (GAFs) in C. parasitica. This is the first confirmed 
GAGA repeats binding regulator identified in fungi that functions in the regulating of 
various downstream transcription factors and downstream genes involved in diverse























wide transcription process by promoting the chromatin decomposition for releasing the
DNA segments for transcription polymerase and other factors.
By mimicking the vegetative incompatibility process using rapamycin, the
recognition sequence of CPVIB-1 was shifted slightly to target genes involved in the
autophagy, phosphorylation, sporulation, cell redox hemostasis, protein glycosylation, 
exocytosis, and the TOR signaling pathway. With the treatment by rapamycin, the
FLAG-tagged CPVIB-1 protein targets 357 genes and only 33.9% of them were
significantly altered in the transcriptome profile of the CPVIB-1 deletion strain, but there
were a few new noteworthy targets. 
The apoptosis-inducing factor 2 gene encodes an oxidoreductase, which plays a
role in mediating the apoptotic cell death by binding to a sequence-specific DNA site
[143]. The LAE secondary metabolism regulator coordinates response to light in 
Aspergillus and regulates T-toxin production, virulence, oxidative stress response and cell
development of maize pathogen Cochliobolus [144]. The cAMP-independent regulator 
PAC2 was found to be required for sporulation, regulating the meiotic cell cycle and 
negatively regulating cell fusion [145]. Furthermore, the identified C. parasitica version 
of cAMP-independent regulator PAC2 was significantly up-regulated in the CPVIB-1-
lacking strain. Lastly, the aspartic protease PEP1 gene, encodes a secreted aspartic
endopeptidase that contributes to the virulence [146]. In conclusion, there is a remarkable
confluence of the phenotypic characteristics of a strain lacking CPVIB-1 and the specific
gene targets that this procedure has revealed that are involved in programmed cell death, 

















Intriguingly, with the treatment of rapamycin, CPVIB-1 was found to target the
TOR2 subunit STE20, one component of the TOR Complex [147]. The TOR signaling 
pathway includes two segments, TOR1 and TOR2 [102]. TOR1 is the interaction site for 
rapamycin and is responsible for regulating the sensing of stress, growth factors, nutrients
to regulate the protein synthesis, lipid and nucleotide synthesis, and autophagy. TOR2 
was found to be insensitive to rapamycin but sensitive to growth factors that regulated 
survival and proliferation [102]. Meanwhile, two other genes, the hybrid signal
transduction histidine kinase K and acetate kinase, were targeted by CPVIB-1 during the
rapamycin treatment with the highest peak scores and they are involved in the
phosphorylation and the phosphorelay signal transduction biological processes. With the
discovery that the TOR contained a C-term kinase domain, it was found to play a central
regulator role in an abundant and diverse set of genes which are important for cell growth 
by reacting with related kinase family proteins [102]. In conclusion, in the presence of 
rapamycin CPVIB-1 targets the TOR2 and other kinases which are involved in the TOR 
signaling pathway.
Ultimately, we have shown that both the carbon starvation and rapamycin inhibit
the TOR signaling pathway leading to the autophagy and inhibition of cell growth, 
consistent with other systems. However, CPVIB-1 was found to target TOR2 expression 
and be induced by rapamycin and carbon starvation treatment. Therefore, we propose a
model such that rapamycin or a nutrient starvation signal targeting TOR1 results in 
changes to CPVIB-1 expression. This, in turn, affects TOR2-regulated pathways by 


























mechanism whereby CPVIB-1 acts as a mediator to link the separate regulatory regimes








     




      
    
    
  
   
 
 
    




     





    
   





    
    




     
    
    
    
    
    





















10 mM NaH2PO4; 




Digestion Buffer 1 % β-glucuronidase [Sigma G-7770];
0.2 % Lysing enzyme [Sigma L-1412];




Trapping Buffer 0.4 M Sorbitol;
100 mM Tris-HCl pH 7.0
autoclave
sterilization
STC 1 M Sorbitol;
100 mM CaCl2; 
100 mM Tris-HCl pH 8.0
autoclave
sterilization
PTC 40 % Polyethylene glycol 4000 MW;







0.1 % Yeast Extract;






2.4 % PDA; 
0.7 % malt extract agar;
0.2 % yeast extract;
0.08 % tannic acid;
0.005 % mg Bromocresol Green;
0.06 % drops Tween 20;
2 % BD BactoTM Agar



























    
   
 
 











   
  
 
0.1 % SDS, pH 8.3
TBST 20 mM Tris;
150 mM NaCl;
0.05 % Tween 20, pH 7.6
No sterilization




PB Buffer 75.4 mM Na2HPO4;
24.6 mM NaH2PO4 
autoclave
sterilization
MTT Solution 50 mg Thiazolyl Blue Tetrazolium
Bromide; dissolved in 10 ml PB Buffer
filter sterilization





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
 




      






Figure 5.1 Phenotype recovery assay from the Dcpvib-1 strain with the FLAG-tagged 
CPVIB-1 expression vector.
(A) The representative phenotype of Dcpvib-1 strain with profuse sporulation and 
reduced aerial hyphal growth compared to the representative phenotype of its isogenic
EP155 strain (B). 
(C) The representative phenotype of the FLAG-tagged CPVIB-1 strain with the
expression vector transformed into the Dcpvib-1 strain (C) was partially recovered















Figure 5.2 Vegetative incompatibility assay of C. parasitica.
(A) EP155 wild type demonstrated incompatibility with EU1. (B) Deletion of cpvib-1
from both EP155 and EU1 converted them to the compatible fusion with each other. (C) 
The FALG-tagged CPVIB-1 expression vector transformed in the Dcpvib-1 strain





   
 







Figure 5.3 Cankers display of the virulence assay with various C. parasitica strains
infecting the American chestnut stems.
The representative cankers on dormant chestnut stems were caused by C. parasitica after 

















Figure 5.4 Cankers size analysis of the virulence assay with various C. parasitica 
strains infecting the American chestnut stems.
Boxplot represented the cankers size from virulence assay. Each dot represented the
canker size of one sample, the horizontal line in the middle of the box represented the
mean number of the cankers size in each strain and the vertical line at the bottom of the





    
   
     
 
  
     
    
 
 
Figure 5.5 The cpvib-1 mutant strain showed less viability reduction when treated 
with rapamycin. The proportion of viable cells were measured using the
MTT viability assay with and without 10 ng/ml rapamycin treatment.
The y axis is the absorbance/mg fungal tissue obtained from the spectrophotometer at 570 
nm wavelength. The x axis is the rapamycin treatment (Green bars) and PB buffer control
(Red bars) within two strains. The black line at the top of each bar is the standard 





   
 
  
    
      
    
    
   





Figure 5.6 The representative image from western blot assay of FLAG-tagged CPVIB-
1 proteins from the nutrient starvation and rapamycin treatment. 
Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, 25 µg total proteins from EMM Medium culture, 
lane 2, 25 µg total proteins from EMM Medium culture with 10 ng/ml rapamycin, 
lane 3, 25 µg total proteins from EMM-Low glucose culture, 
lane 4, 25 µg total proteins from EMM-Low glucose with 10 ng/ml rapamycin, 
lane 5, 25 µg total proteins from EMM-No Nitrogen culture, 











   











Figure 5.7 The representative image from western blot assay of the FLAG-tagged 
CPVIB-1 protein using anti-FLAG antibody.
Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, 80 µg total proteins from the positive FLAG-tagged CPVIB-1 strain treated with 
10 ng/ml rapamycin, 
lane 2, 80 µg total proteins from the positive FLAG-tagged CPVIB-1 strain (positive
control), 
lane 3, 80 µg total proteins from EP155 strain (negative control), 






   
 
      









    
Figure 5.8 The representative image from western blot assay of the
immunoprecipitated FLAG-tagged CPVIB-1 protein.
(A) the western blot image using anti-FLAG primary antibody, (B) the western blot
image using anti-Ub antibody.
Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins of the positive FLAG-tagged CPVIB-1 strain (positive control),
lane 2, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins from the positive FLAG-tagged CPVIB-1 strain treated with 10 ng/ml rapamycin 
lane 3, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins from EP155 strain (negative control), 
lane 4, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total










    
(A)
(B)
Figure 5.9 Per base sequence quality plot of sample 1 from FastQC.
X axis is the position in reads (150 bp for each read), Y axis is the sequencing quality 
score (Above 30 are considered high quality) (A) The plot was from the original reads of 




            
 
                              
 









Figure 5.10 MACS2 models for peaks in FLAG-tagged-CPVIB-1 samples and the
FLAG-tagged-CPVIB-1-Rapamycin samples.
X axis is the distance to the middle point of the peaks, and Y axis is the distribution 
percentage of tags.
(A) The 5’ strand-separated tags from the FLAG-tagged-CPVIB-1 sample were aligned 
by the center of their forward and reverse peaks. (B) The 5’ strand-separated tags from
the FLAG-tagged-CPVIB-1-Rapamycin sample were aligned by the center of their 












Figure 5.11 Three examples of peaks identified in the promoter regions of annotated 
genes.
(A) Two peaks were identified in the promoter of the same gene from both FLAG-tagged 
CPVIB-1 samples and its Rapamycin treatment samples (highlighted with black arrows). 
(B) The peak was identified in the promoter of the gene from only FLAG-tagged CPVIB-
1 samples (highlighted with red arrows). (C) The peak was identified in the promoter of 


















































































































             
   









Figure 5.12 The predicted recognition sequences of FLAG-tagged CPVIB-1 samples.
(A) The GAGAGAGA recognition sequence of FLAG-tagged CPVIB-1 protein. (B) The
distance between the center of predicted recognition sequences and the peaks summit. (C) 











               
 
      














































Figure 5.13 The predicted recognition sequences of FLAG-tagged CPVIB-1-
Rapamycin samples.
(A) The similar (GA)n recognition sequences of FLAG-tagged CPVIB-1-Rapmaycin 
samples. (B) The distance between the center of predicted recognition sequence and the
peaks summit. (C) The top rank HOMER known genes with similar recognition 













Figure 5.14 The “Scatterplot & Table” view of REVIGO showing the GO clusters of 
the direct targeted genes by FLAG-tagged CPVIB-1 protein.
The y axis represents the peak score of each GO term.
The x axis represents the semantic scale of the GO terms. 
The bubble color indicates the log2 fold change value from the positive (red, up-
regulated) to negative (blue, green, and yellow down-regulated). The size of the bubble















Figure 5.15 The “Scatterplot & Table” view of REVIGO showing the GO clusters of 
the direct targeted genes by FLAG-tagged CPVIB-1 protein and 
significantly altered in transcriptional level in the Dcpvib-1 mutant strain.
The y axis represents the log2 fold change of each GO term.
The x axis represents the semantic scale of the GO terms. 
The bubble color indicates the log2 fold change value from the positive (red, up-
regulated) to negative (blue, green, and yellow down-regulated). 












Figure 5.16 The “Scatterplot & Table” view of REVIGO showing the GO clusters of 
the direct targeted genes by FLAG-tagged CPVIB-1 protein with 
rapamycin treatment.
The y axis represents the peak score of each GO term.
The x axis represents the semantic scale of the GO terms. 
The bubble color indicates the log2 fold change value from the positive (red, up-
regulated) to negative (blue, green, and yellow down-regulated).







   
 
  
   
 
 
Figure 5.17 The “Scatterplot & Table” view of REVIGO showing the GO clusters of 
the direct targeted genes by FLAG-tagged CPVIB-1 protein with 
rapamycin treatment and significantly altered in transcriptional level in the
Dcpvib-1 mutant strain.
The y axis represents the log2 fold change of each GO term.
The x axis represents the semantic scale of the GO terms. 
The bubble color indicates the log2 fold change value from the positive (red, up-
regulated) to negative (blue, green, and yellow down-regulated). 

















   
 
DISCUSSION
Significance of a re-annotated C. parasitica genome
In 2002, Ouzounis defined the term, re-annotation, stating the trend and 
requirement for genome re-annotation to discover more gene and protein functions, test
and refine the mistakenly predicted genes, and perform the comparison of existing and 
newly developed methods [148]. Next generation sequencing (NGS) technologies create
great opportunities for various genomics, transcriptomics, and proteomics projects of 
exotic non-model organisms [80; 149]. Meanwhile, the drive for re-annotation of the
prior existing genomes arises with the up-to-date evidence, such as transcriptomic and 
proteomic datasets as well as the newly developed bioinformatics tools. [150]. As the
most significant factor for judging the various versions of annotation, quality assessment
always represents a great challenge and raises a serious issue since then [148]. For 
example, the genome of C. parasitica was sequenced, annotated, and released in 2009 
using the technology and tools available at that time, but did not contain any quality 
assessment step. 
In this study, with deep transcriptome sequencing and updated protein evidence, 
re-annotation of C. parasitica genome is more accurate and informative compared to the
prior version. Furthermore, since MAKER2 is the first bioinformatics tool to provide a

















   
  
 
problematic predicted gene models for further manual curation and also gave a measure
for the comparison of two annotation versions.  
This significantly improved genome annotation (2017-version) not only serves the
purpose to provide accurate and informative results for characterizing the roles of 
CPVIB-1 using RNA-Seq and ChIP-Seq projects, but also provides a valuable resource
for researchers who are interested in both comparative and functional studies of C. 
parasitica. The integrated annotation analysis by applying the MAKER2-two-pass
pipeline has facilitated the improvement of the genome annotation, and this approach can 
be applied to other biological systems.
Development and application of PEPA, a prior genome annotation evaluation
pipeline
In 2009, Bakke reported a comparison of three automated genome annotations, 
the Joint Genome Institute (JGI), the National Microbial Pathogen Data Resource
(NMPDR) and the J. Craig Venter Institute (JCVI) [151]. Later in 2013, a semi-
automated genome annotation comparison scheme was developed to perform the
functional comparison only [75]. In 2011, MAKER2 was developed to attach a quality 
assessment system to the automated genome annotation, which providing a means to 
compare the annotations in quality aspect besides the structural and functional features
[48].
PEPA is a pipeline designed for the evaluation of any pre-existing genome
annotation with no quality metric system. It is a simple pipeline that was developed to 
comprehensively estimate the accuracy of each prior predicted gene model, to provide




   
  
  
   
   
  
 










   
and enrich the gene models with a quality metrics system and internal domains (InterPro 
ID). It also contained a R script to perform a comparison of the prediction quality of all
gene models from the prior annotation and the newer version. Finally, it included a 
python script that was developed to sort each individual gene model from the prior 
genome annotation into four categories (Match, Similar, Different, Noexist) based on 
their discrepancies with the newer version. 
The PEPA evaluation pipeline has a significant benefit for the future work in C. 
parasitica by providing reliable insights of each predicted gene model that researchers
are interested in with the new quality metrics system and sorting system. It also has
profound impact to the genome projects of exotic non-model organisms, in which the
structural and functional accuracy of a predicted gene model is extremely important for 
characterizing it by developing the knock-out constructs. To the best of our knowledge, a
comprehensive pipeline designed to evaluate a prior genome annotation, regardless of the
format against a newer version, has not been presented yet to illustrate the structural and 
functional differences of each gene model and its accuracy.
Structure of CPVIB-1
CPVIB-1 is a NDT80/PhoG-like transcription factor
CPVIB-1 is predicted to be a putative p53-like transcription factor from the
InterPro Protein sequence analysis and classification website (Figure 6.1) [152]. The
NDT80-DNA binding domain (PRU00850) is found in proteins with size ranging from
185-382 amino acids that have transcription factor activity and many are thought to 
response to celluar nutritional status (https://prosite.expasy.org/rule/PRU00850). NDT80-























fungi and Amoebozoa [31]. The number of these genes present in the genome varies in 
the fungi, ranging from zero to six in the Ascomycota class [153]. Before this study, the
analysis of NDT80-like genes has only been completed in three fungal species, the
haploid ascomycetes S. cerevisiae, Aspergillus nidulans, and N. crassa, which contain 
one, two and three NDT80-like genes, respectively [30; 154]. In C. parasitica, there are
three NDT80-like genes identified in the 2017-version annotation:
Ep155_U_G00001434, similar to transcription factor vib-1; Ep155_U_G00009104, 
similar to transcription factor pacG; and, Ep155_U_G00004090, similar to meiosis-
specific transcription factor NDT80. All of them were predicted to be transcription 
factors and orthologs of VIB-1 gene in N. crassa, pacG gene in A. nidulans, and NDT80 
gene in S. cerevisiae, respectively [32; 154-155]. 
The NDT80-DNA binding domain in yeast is comprised of a b-sandwich core
with seven b-strands and three short a-helices and shows high structural conservation 
with similar domains from N. crassa, D. melanogaster, and humans, and is absolutely 
conserved in the positions that are identified to interact with DNA [156]. The SWISS-
MODEL was used to predict the quaternary structure of CPVIB-1 and the same b-
sandwich core was observed with an additional six b-strands and short a-helices
(https://swissmodel.expasy.org/) (Figure 6.2). In this study, CPVIB-1 is the first NDT80-

















   
 
 
Ubiquitin decoration in CPVIB-1
Transcription factors comprise a relatively small portion of genome, 
approximately 7% in humans and 1.1% in C. parasitica (2017-version annotation) and 
function as the gatekeepers of cellular functions, integrating signal transformation into 
the activation/repression of gene expression that reconfigures the cell physiology in real
time [157]. Post-translational modifications (PTMs) regulate the function, abundance, 
and activity of the transcription factors in every aspect [157]. Among all the PTMs, the
more prominently studied are phosphorylation, methylation, glycosylation, acetylation, 
sumoylation, and ubiquitination [129; 157-160]. In all the well-studied PTMs, the
ubiquitination modified transcription factors are found to be the least prevalent in
humans[157]. Ubiquitin is a small protein that is covalently linked to the lysine side chain 
of substrates by the cognate E3 ligase. This may occur at single or multiple lysine
residues [161]. Generally, poly-ubiquitination of transcription factors marks them for 
degradation through the proteasomal system, which is called the ubiquitin-dependent
proteolysis pathway [129; 159]. 
In this study, the ubiquitin modification of CPVIB-1 was predicted using UbSite
online tool (http://csb.cse.yzu.edu.tw/UbiSite/), where the protein sequence of CPVIB-1 
was predicted to have eight ubiquitination sites (Ubi-sites) with relatively high 
confidence scores (Figure 6.3). Consistent with the above identification, CPVIB-1 was
found to be covalently attached with at least one ubiquitin proteins from western blot
assay in one or multiple sites, and its ubiquitinated-version comprised the major portion 
of total cellular CPVIB-1. It is most likely that the non-ubiquitinated version is the one








   
    
 








sufficient DNA bound to CPVIB-1 protein compared to other ChIP-Seq projects, it can 
be speculated that the poly-ubiquitination of CPVIB-1 leads to the degradation through 
the classic proteolysis pathway, which regulates the level of active CPVIB-1 protein in 
cells [99; 109]. 
Functions of CPVIB-1
NDT80-DNA binding transcription factor CPVIB-1
In budding yeast (S. cerevisiae), the NDT80-like protein is required for the
completion of meiosis [154]. In the pathogenic Candida albicans, the CaNDT80-like
protein is required for antifungal drug resistance, hyphal growth, biofilm formation, and 
virulence [162-164]. In the filamentous fungus A. nidulans, NDT80-like XprG is a
regulator of a large number of genes involved in carbon starvation, extracellular protease, 
mycotoxin and penicillin production [31; 153; 165]. In N. crassa, VIB-1 is required for 
expression of genes that are involved in vegetative incompatibility-induced programmed 
cell death and is also a regulator for the genes involved in nutrient starvation [32; 34; 79]. 
In C. parasitica the ortholog of the above NDT80-like transcription factors, CPVIB-1, is
a regulator of vegetative incompatibility programmed cell death, hyphal growth, 
sporulation, and virulence. 
This study is the first to attempt characterization of the targets of the NDT80-like
transcription factor CPVIB-1. By using large-scale transcriptome comparison analysis, 
the regulating mechanisms behind the above functions can be understood. For example, 
the role of CPVIB-1 in carbon metabolism CPVIB-1 has been identified to regulate at 
least five various but directly related KEGG carbon pathways that repress glucose






    
 
 









   
 
starvation treatment using western blot assay that is congruent with the above
transcriptome analysis results. Meanwhile, CPVIB-1 has also been determined to regulate
various genes related to the pathogenesis. Perhaps the regulation of carbon metabolism-
related genes by CPVIB-1 is an important response during the plant host infection 
process, which could explain the reduced virulence of the Cpvib-1 deletion strain (Figure
6.4). However, we also found that CPVIB-1 is a universal regulator that is essential for 
RNA process, cellular biosynthesis processes, responses to stress, and hundreds of other 
genes with diverse functions (Figure 6.4). With the studies from the NDT80-like
transcription factors in the above model fungal species, transcriptomics alone failed to 
provide insights to further explain the targets of CPVIB-1. Therefore, we performed the
ChIP-Seq to explore the direct targeted genes of CPVIB-1. 
GAGA factor CPVIB-1
In Drosophila, GAGA factor (DmGAF) has an extraordinarily diverse set of 
functions that include the activation and silencing of gene expression, nucleosome
organization, remodeling chromosome architecture and mitosis by directly interacting 
with a small subset of target genes and indirectly interacting with many others to serve
varied functions [96]. In vertebrates, all GAGA factors (vGAF) contains N-terminal
BTB/POZ domains, four C-terminal zinc finger domains for the (GA)n specific DNA
binding, and multiple PTM sites for phosphorylation, acetylation, and ubiquitination. 
Similar to the function of DmGAF in Drosophila, vGAF play roles in gene activation, 
repression, enhancer blocking, and cell development and differentiation [166].
In this study, using the ChIP-Seq method, CPVIB-1 has been identified as the first














with 264 genes that function in remarkably diverse range of regulatory contexts, 
including activation/repression of transcription, mitosis maintenance, cell development, 
autophagy, cell-cell communication, virulence, nucleosome assembly, and others. 
Furthermore, CPVIB-1 was found to bind to sequences thought to control a DNA
helicase for mitosis, telomere maintenance and the decomposition of the chromatin 
complex as well as the activators for the transcription of RNA polymerase II promoter for 
the promotion of the transcription process. Like the GAGA factors in Drosophila and 
human, CPVIB-1 is a multifaceted transcription factor with diverse roles in gene
activation and repression, maintenance of mitosis and cell development (Figure 6.5) 
[166].
CPVIB-1 functions in the TOR signaling pathway
Our interest in the role and function of CPVIB-1 stemmed from the observation 
that this protein is required for the response to certain vegetative incompatibility 
responses. In P. anserina, the idi gene, which is induced during programmed cell death 
and triggered by vegetative incompatibility, was also found to be induced upon nitrogen 
and carbon starvation [105]. In the same study, a well-known pathway response to 
nutrient signals, the TOR kinase pathway, was linked to the vegetative incompatibility 
and rapamycin was demonstrated to be capable of inducing the expression of idi gene to 
mimic the vegetative incompatibility [105]. 
In this study, rapamycin and the carbon starvation was found to induce the
accumulation of CPVIB-1 protein. Moreover, CPVIB-1 was found to positively 
correlated with the action of rapamycin to inhibit the fungal cell growth.  To explore the




   
 















the ChIP-Seq method was applied to identify the recognition sequence bound by the
CPVIB-1 protein. The recognition sequence of CPVIB-1 upon rapamycin treatment was
found to be slightly shifted to a flexible (GA)n motif and, therefore, the annotated genes
associated with this altered recognition sequence were shifted as well. In particular, 
CPSTE20, a TOR2 complex subunit, and CPRGA1, a Rho-type GTPase-activating 
protein, were found to be in this adjusted set of CPVIB-1 protein targets. 
In yeast Ste20p, also known as the ortholog of Avo3p, is the largest subunit of 
TORC2 complex and the C-terminal part of Ste20p, is located close enough to the
rapamycin binding domain of TORC2 to protect it from the binding of rapamycin in yeast
[167-168]. Rga1p plays a crucial role in activating multiple GTPase genes, major 
components in the MAPK cascade for the activation of the TOR2 signaling pathway
[169-170] . Both of these genes code for critical proteins involved in the TOR signaling 
pathway and the data presented here indicates they are regulated directly by CPVIB-1 
upon the treatment of rapamycin. 
A new interpretation of the TOR signaling pathway that includes CPVIB-1
In yeast, the macrolide antifungal chemical rapamycin was found to bind to 
peptidyl-prolyl cis-trans isomerase, also as known as Fpr1p. [101; 171-173]. 
Subsequently, from the mutants that conferred resistance to rapamycin, the target of 
rapamycin was identified [171; 174]. There were two novel proteins, Tor1p (target of 
rapamycin 1) and Tor2p (target of rapamycin 2), that were found to physically interact





   
  
   




   
 
  
   
   
  
    




   
The domain structure and amino acid sequences of Tor1p and Tor2p are
evolutionarily conserved [175]. In yeast, both of them contain the HEAT repeats, FAT, 
FRB, kinase, FIT and FATC (Figure 6.6). Although the primary structure of the Tor1p
and Tor2p are highly similar to each other, their cellular functions are distinct [175; 179]. 
The kinase activity of TOR complex 1 (TORC1) is found to be essential for cell growth 
by promoting anabolism, such as protein biosynthesis, lipid biosynthesis and nucleotide
biosynthesis for the need of new cells by phosphorylating proteins, promoting mRNA
translation initiation process, promote ribosome biosynthesis [102; 113]. TORC1 also 
represses catabolism, such as autophagy and ubiquitin-proteasome system [102]. While
TORC1 regulates cell growth and metabolism, the kinase activity of TOR complex 2 
(TORC2) controls proliferation and survival process by phosphorylating several
downstream protein kinases and regulating the glucose utilization in humans by 
responding to insulin signal [102; 113].
This functional distinction between them is due to the differences in the
composition of the TOR complexes. TORC1 is composed with either Tor1p or Tor2p as 
the back-bone protein, and Kog1p, Tco89p, and Lst8p are subunits (Figure 6.5) [180-
182]. In TORC2, there are Tor2p is always the TOR protein and is assembled with the
subunits of Avo1p, Avo2p, Avo3p, Bit61p, and Lst8p (Figure 6.6) [183-186]. Avo3p is 
found to be an essential scaffold protein to assemble TORC2 and interact with FAT and 
kinase domains of Tor2p within TORC2 to prevent the accessibility from the FKBP12-
rapamycin complex [186]. Because of this, TORC1 is sensitive to rapamycin treatment, 



















In C. parasitica, CPVIB-1 was associated with the promoter region of cpste20, 
encoding a ortholog protein of Avo3p following the treatment with rapamycin [168]. The
binding recognition motif of CPVIB-1 in this promoter region is GAGAAGAGC 
following the treatment with rapamycin, which is slightly shifted from GAGAGAGA
under untreated conditions. Rapamycin is known to target TORC1 to inactivate its
function. We have shown that CPVIB-1 protein accumulated to higher levels following 
rapamycin treatment or glucose starvation. Our data from RNA-Seq showed that in the
∆cpvib-1 strain glucose utilization is significantly and consistently upregulated. 
Therefore, we propose that a function of CPVIB-1 is to repress this pathway, opposite to 
the role of TORC2. Similarly, CPVIB-1 appears to be required for the repression of
protein, lipid, and steroid biosynthesis, and activation of autophagy and proteolysis, 
which is opposite to TORC1. Furthermore, our data also shows by ChIP-Seq that CPVIB-
1 can bind to the promoter regions of cpste20, which encoding protein to protect TORC2
from rapamycin action, but the regulation interplay between TORC1 and TORC2 was
observed but not understood. Based on the results of this study, we proposed a revised 
model of TOR signaling that places CPVIB-1 between the TORC1 and TORC2. To be
responsible for inducing the cell death autophagy in vegetative incompatibility, CPVIB-1 
is repressed by TORC1 under normal conditions. However, during the nutrient starvation 
or rapamycin treatment, TORC1 is initially inactivated, which led to the increased 
accumulation of CPVIB-1. In turn, CPVIB-1 bound the promoter of cpste20 repressing 
its transcription and, presumably its protein abundance, thereby resulting in less









     













both TORC2 and TORC1 resulting in more profound effects of inhibition of cell growth, 
cell survival and proliferation (Figure 6.7).
Future directions
Because our predicted model of the function of CPVIB-1 in TOR signaling 
pathway superseded our earlier transcriptome work, we do not have transcriptome
profiling data of C. parasitica following treatment with rapamycin. Therefore, an 
immediate first strategy would be to perform transcription level comparison of cpste20
between C. parasitica EP155 strain and its isogenic Dcpvib-1 strain under the same
conditions of rapamycin treatment as the ChIP-Seq experimental design. Also, it is
necessary to perform the comparison analysis against to the EP155 strain and its isogenic
Dcpvib-1 strain without rapamycin treatment. If rapamycin targets TORC1 leading to the
induction of CPVIB-1, leading to the repression of cpste20, rendering TORC2 vulnerable
to rapamycin, we can predict that the cpste20 will be repressed in transcript level in 
EP155 strain in rapamycin treatment with the presence of CPVIB-1 compared to in 
Dcpvib-1 strain upon the same condition of rapamycin treatment without the presence of 
CPVIB-1 as well as in EP155 strain without the rapamycin treatment.
A second option would be to test the potential for CPSTE20 protein detection 
using the commercial anti-STE20 antibody, subdomain VI from yeast (Sigma-Aldrich, 
USA).  If this was cross-species functional as a detection tool, we could test the
prediction that the accumulation of CPSTE20 protein will be decreased in EP155 strain 
following rapamycin treatment in the presence of CPVIB-1 compared to the Dcpvib-1














   
 







The TOR signaling system is known as one of the signal network systems that has
been evolutionarily conserved among eukaryotes [103; 187; 188]. In higher eukaryotes, 
such as in humans, mammalian TORC1 (mTORC1) plays a central role in regulating all
of the downstream factors and therefore controls the balance between anabolism and 
catabolism in response to the environmental conditions [113]. Dysfunctions in the TOR 
signaling network can closely correlate with pathological conditions including diabetes, 
cancer, obesity, and neurodegeneration [187]. However, for the TORC2, because the
knockout of TOR2 gene in yeast is lethal and TORC2 is resistant to rapamycin, the
studies of upstream and downstream factors of TORC2 signaling haven’t been 
extensively investigated [113; 189]. Here we present a potential inhibition strategy for 
TORC2, rapamycin with the CPVIB-1, in C. parasitica. With this strategy, an immediate
third idea would be to perform the transcriptome sequencing of C. parasitica EP155 
strain and its isogenic Dcpvib-1 strain under the same conditions of rapamycin treatment
as the ChIP-Seq experimental design. With the transcriptome data available, it would be
possible to perform the comparison analysis against to the transcriptome EP155 strain 
and its isogenic Dcpvib-1 strain as in Chapter III. The transcriptome comparison analysis
can be used to reveal the downstream factors of TORC2 signaling pathway with the
above inhibition strategy. Meanwhile, the genes downstream of TORC1 are responsible
for regulating CPVIB-1 can also be revealed using the same strategy. Furthermore, the
transcriptome comparison analysis of the EP155 strain with and without rapamycin 
treatment can be used to understand the mechanism of TORC1 slightly shifting the































































Figure 6.5 The biological processes regulated by CPVIB-1 from the ChIP-Seq
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Figure 6.6 TOR complexes in C. parasitica modified from S. cerevisiae [113].
(A) represents the components of TORC1 and (B) represents the components of TORC2, 
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Figure A.1 Figure 1 of agarose gel pictures for validation of 27 predicted gene models (2009-
version and 2017-version) using PCR.
(1KB) M is 1Kb size ladder, and lane 1, 4, 7, 9, 11 and 14 are the genomic DNA product of 
gene1, gene4, gene8 (2017-version), gene8 (2009-version), gene10 and gene17, separately. The



















Figure A.2 Figure 2 of agarose gel pictures for validation of 27 predicted gene models (2009-
version and 2017-version) using PCR.
lane 1, 3, 5 and 8 are the genomic DNA product of gene3(2009-version), gene3(2017-version), 
gene5 and gene7, separately, and M (100bp) is 100bp size ladder. The other lanes’ information is



















Figure A.3 Figure 3 of agarose gel pictures for validation of 27 predicted gene models (2009-
version and 2017-version) using PCR.
(100 bp) M is 1Kb size ladder, and lane 1, 4, 7, 10, 13 and 16 are the genomic DNA product of 
gene2, gene9, gene11, gene12, gene13 and gene14, separately. The other lanes’ information is





    
 















Figure A.4 Figure 4 of agarose gel pictures for validation of 27 predicted gene models (2009-
version and 2017-version) using PCR.
(1KB) M is 1Kb size ladder, and lane 1, 4, 6, 8, 10, 12 and 14 are the genomic DNA product of 
gene 21, gene 23, gene24, gene25, gene26, gene27 and gene22, separately, and in the end 





















Figure A.5 Figure 5 of agarose gel pictures for validation of 27 predicted gene models (2009-
version and 2017-version) using PCR.
(100bp) M is 100bp size ladder, and lane 1, 4, 7, 10, 13 and 16 are the genomic DNA product of 
gene6, gene15, gene16, gene18, gene19 and gene20, separately. The other lanes’ information is
listed in the Table 3.3.
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